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ABSTRACT 
Intervention strategies against malaria have two major aims: to reduce disease 
prevalence and severity. However, these aims are frequently not achieved. This 
thesis experimentally addresses how intervention strategies - namely antimalarial 
chemotherapy and vaccination - affect the transmission and virulence of malaria 
parasites at the phenotypic level. Most forms of antimalarial chemotherapy and 
potential vaccines act against the parasite stage responsible for the pathology: the 
asexually replicating erythrocytic forms. A proportion of these asexual parasites, 
which increases when conditions are bad for asexual replication, develop into non-
replicating gametocytes, the only stages capable of infecting the mosquito vector. 
Gametocyte densities generally correlate with transmission success. 
Studies using the rodent malaria Plasmodium chabaudi in laboratory mice revealed that 
a variety of antimalarial drugs (used in doses that killed most, but not all parasites), 
administered before or after infection, resulted in an increase in the proportion of 
asexual parasites that developed into gametocytes (gametocytogenesis). As a result, 
gametocyte densities (and where assayed, subsequent transmission to Anopheles 
stephensi mosquitoes) did not differ from control infections, or were only slightly 
less. Similarly, sub-curative treatment with the antimalarial drug chloroquine resulted 
in a five-fold increase in gametocytogenesis of the human malaria P. falciparum in 
vitro. There was a positive relationship between gametocytogenesis and growth 
inhibition, which differed between clones, independent of drug resistance. Unlike 
previous reports, the antimalarial drug chioroquine was not found to increase the per 
gametocyte infectivity of P. chabaudi. 
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Immunisation against P. chabaudi resulted in a four-fold reduction in total numbers of 
both asexual parasites and gametocytes. Immunity against P. chabaudi was found to 
be strain-specific: inhibition of asexual growth was greater if challenge infections 
were of the same genotype as used for immunisation (homologous challenge), 
compared to when the immunising and challenge clones differed (heterologous 
challenge), although there was no difference in gametocyte numbers. Strain-specific 
immunity also acted on per gametocyte infectivity: gametocytes in a homologous 
challenge were five times less infectious (to A. stephensi mosquitoes) than 
gametocytes in a heterologous challenge, which did not differ in per gametocyte 
infectivity from control infections. Patterns of gametocytogenesis through time in 
control, immunised and drugged animals, were consistent with the parasite responding 
in an adaptive manner to changing environmental conditions. 
Virulence (as measured by host anaemia) was reduced by both chemotherapy and 
immunisation. Differences in virulence between immunised, drugged and control 
animals could be explained by differences in asexual replication. Drugged infections 
achieved the same level of transmission as control infections, but at reduced virulence. 
The relationship between virulence and transmission did not differ between control and 
immunised infections. The evolutionary and epidemiological significance of all these 




1.1 HOSTS, PARASITES AND INTERVENTION 
Parasites, by definition, reduce host fitness. The costs of parasitism are frequently 
huge, resulting in host death (e.g. microsporidians parasitising mosquitoes, Agnew & 
Koella 1997) or loss of reproductive function (e.g. schistosomes parasitising snails, 
Baudoin 1975). As a result, hosts have evolved numerous mechanisms to resist 
parasites, even though these defences might themselves be costly (e.g. Boots & Begon 
1993, Kraaijeveld & Godfray 1997, Yan et at. 1997). Parasite fitness is dependent on 
successfully evading host defences, so that host resources can be exploited. 
Consequently, parasites and hosts can be considered to be in an evolutionary arms 
race: selection for host resistance results in selection on parasites to evade host 
defences (Anderson & May 1991). For some host-parasite interactions, this arms race 
has evolved to occur on a phenotypic level. For example, the mammalian immune 
system is capable of rapidly recognising and responding to parasite antigens, although 
more time is required if the antigen is novel. Both trypanosomes and malaria parasites 
constantly change which antigen they express on their surface during an infection, so 
as to evade the immune system (e.g. Turner 1997, Roberts et at. 1992). 
Selection on parasites to evade host defences will often be stronger than selection on 
hosts to resist parasites. First, a parasitised host may still have some reproductive 
success, whereas a parasite without a host is likely to have none. Second, not all 
hosts are parasitised, whereas all parasites require a host. Moreover, parasites 
generally have shorter generation times than their hosts, thus respond to selection more 
rapidly. Consequently, parasites are likely to stay one step ahead of their hosts. 
Artificial control of parasites of medical or economic importance is therefore 
necessary. 
Anti-parasite intervention aims to reduce the prevalence of the parasite (by reducing its 
transmission) and / or the pathology it causes. Unfortunately, parasite transmission is 
intimately linked with parasite fitness (Anderson & May 1982), so that there will be 
intense selection on the parasite to minimise the fitness consequences of intervention. 
For example, resistance to anti-parasite drugs has been reported in nematodes (Conder 
& Campbell 1995), HIV (Larder & Kemp 1989), and malaria parasites (Peters 1987), 
to name but a few. 
1.2 ANTIMALARIAL INTERVENTION 
Intervention strategies used against malaria fall into two main categories. First, 
intervention which acts against the asexually replicating blood-stage parasites (figure 
1. 1), which aims to reduce both transmission and pathology. Examples include most 
antimalarial drugs and most potential vaccines (Greenwood 1997). Second, 
intervention that solely aims to reduce transmission. This includes reducing the vector 
population (through the use of insecticides and reducing available mosquito breeding 
sites), reducing the frequency of mosquitoes biting (e.g. bed nets), and forms of 
vaccination (transmission-blocking; Sinclen 1997) and chemotherapy (e.g. primaquine) 
that specifically target parasites stages infective to the mosquito (gametocytes or the 
resultant gametes, figure 1.1). 
1.3 ANTIMALARIAL INTERVENTION AND TRANSMISSION 
Ideally, intervention strategies will reduce transmission to the extent that the parasite 
population cannot maintain itself (i.e. the average number of new infections resulting 
from an established infection (R 0) is reduced below one; Anderson & May 1982). 
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Figure 1.1 (over): Life-cycle of generalised mammalian malaria parasites. A 
mammalian malarial infection is initiated by the inoculation of one or more haploid 
sporozoites by an infected mosquito taking a blood meal. These sporozoites migrate to 
the liver, where they invade hepatocytes and undergo extensive asexual replication. 
The resultant parasites make their way to the bloodstream where further cycles of 
asexual replication occur within red blood cells. It is this parasite stage that is 
responsible for the pathology of a malarial infection. A small proportion of the 
asexually replicating parasites, rather than undergo further rounds of asexual 
replication, develop into non-replicating gametocytes. These are the only stages 
capable of infecting the mosquito vector. When gametocytes are taken up in a 
mosquito blood meal, they develop into male and female gametes which fuse into a 
motile ookinete. The ookinete penetrates into the midgut wall, where it develops into 
an oocyst. Within the oocyst, meiosis and recombination occur (Walliker et al. 1987). 
The meiotic products undergo mitotic replication, resulting in thousands of haploid 
sporozoites. These migrate to the mosquito salivary glands, where they are inoculated 
into the next host that the mosquito feeds on. Reproduced with permission from 
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Despite successful eradication of malaria from, for example, Sardinia and Corsica, 
larger scale eradication programmes in the rest of the world have generally failed 
(Gramiccia & Beales 1988). As a result, modern control programmes are less 
ambitious, aiming only to reduce transmission and pathology (Bruce-Chwatt 1985). 
This has been successfully achieved at times. For example, a meta-analysis of results 
from a number of field trials using insecticide-impregnated bed nets showed that the 
incidence of malaria was reduced by approximately 50% (Choi et al. 1995). Similarly, 
malaria prevalence was reduced following a combination of chemotherapy and vector 
control in the Sudan Savanna (Molineaux & Gramiccia 1980). However, world-wide 
malaria prevalence certainly has not decreased since the start of consolidated malaria 
eradication and control programmes, with an estimated 300 million people contracting 
the disease each year (Bruce-Chwatt 1985). There are numerous explanations for this 
apparent lack of success, including environmental changes increasing vector 
populations and control programmes not being sufficiently widespread (Gramiccia & 
Beales 1988). However, intervention strategies themselves may be less effective than 
anticipated at reducing transmission for a number of reasons outlined below. 
Host changes 
The transmission success of malaria is frequently negatively correlated with the degree 
of antimalarial immunity of the vertebrate host (e.g. Graves et al. 1988). However, 
under some circumstances immunity can actually increase transmission (Targett 1992). 
More generally, reducing exposure to the parasite by antimalarial intervention can 
decrease host immunity (Molineaux & Gramiccia 1980), potentially resulting in an 
increase in transmission from infected individuals. The well documented evolution of 
mosquito insecticide resistance (Pant 1988) will also greatly reduce the effectiveness of 
this form of vector control. Physiological or behavioural adaptations in the mosquito 
may reduce the effectiveness of other vector control strategies. 
Parasite changes 
Selection on malaria parasites to minimise the fitness costs resulting from antimalarial 
intervention will be very strong. Indeed, resistance to most antimalarial drugs has 
evolved, and is spreading rapidly (Peters 1987). Other adaptive changes might also be 
expected. For example, many free-living organisms minimise fitness costs bought 
about by environmental changes by either genetic (e.g. Reznick et al. 1990, Lafferty 
1993) or phenotypic (e.g. Minchella & Loverde 1981, Crowl & Covich 1990, Trussell 
1996) changes in their life history strategies. Host immunity and chemotherapy 
frequently fail to kill all parasites (e.g. Wernsdorfer 1994), resulting in a reduction in 
circulating parasite numbers and infection longevity. The resultant loss in 
transmission might be partially compensated for by an increase in the proportion of 
asexually replicating parasites that develop into transmission stages (gametocytes). 
Indeed, facultative increases in gametocyte production (gametocytogenesis) appear to 
be a general response to inhibition of asexual replication (Mons 1985, Carter & Graves 
1988, Sinden et al. 1996). These responses might be fine-tuned by intervention-
imposed selection. 
Direct effects 
Intervention strategies may have some (surprising) direct transmission-enhancing 
properties. For example, the antimalarial drug chloroquine has been reported to 
increase the probability of a given density of gametocytes infecting a mosquito 
(reviewed in Butcher 1997). 
1.4 ANTIMALARIAL INTERVENTION AND VIRULENCE 
Any method of antimalarial intervention that kills asexually replicating blood stage 
parasites (most forms of chemotherapy and potential vaccines) is likely to reduce host 
morbidity and the probability of host death (e.g. Alles et al. 1998). However, like 
transmission, the virulence of a malarial infection is likely to be negatively correlated 
with host immunity. Reducing transmission through intervention strategies may result 
in a decrease in host immunity and thus an increase in overall levels of virulence in a 
community (e.g. Snow & Marsh 1995, Trape & Rogier 1996, AIles et al. 1998). 
Parasite virulence is generally believed to be the result of selection acting on parasite 
transmission success (reviewed in Bull 1994, Read 1994, Frank 1996, Ebert & Herre 
1996, Lipsitch & Moxon 1997). Levels of virulence that maximise transmission are 
likely to change with some alterations in environmental conditions (e.g. Bull et al. 
1991). Antimalarial intervention might be one of these. 
1.5 EXPERIMENTAL SYSTEMS 
Plasmodium chabaudi in laboratory mice 
Most of the experiments described in this thesis were conducted using the rodent 
malaria P. chabaudi in laboratory mice. In vivo experiments are important because 
they allow parasites to be studied under relatively natural conditions. Indeed, the 
immune system is likely to be the strongest selective force acting on Plasmodium life 
histories. However, mice are not the natural host of P. chabaudi - the parasite was 
isolated from arboreal thicket rats (Thamnomys rutilans) in Central Africa (reviewed 
by Landau & Chabaud 1994). It has been suggested that patterns of infections are 
very different in these hosts. Natural infections in thicket rats are generally chronic, 
have low parasite densities and are life-long (Landau & Chabaud 1994), whereas 
laboratory-induced infections in mice tend to be short-lived, reach very high parasite 
densities and are often fatal in certain mouse genotypes (Stevenson et al. 1982). 
There are reasons to believe that these striking differences in infection dynamics are a 
result of sampling bias. First, after the primary infection in mice, parasites remain at 
low densities, generally only apparent during subsequent small peaks in parasite 
densities (recrudescences). These recrudescences occur for as long as measurements 
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have been taken (up to 3 months; A. Read & M. Anwar, unpublished data). Such 
'chronic' infections resemble those described in thicket rats. Second, primary 
infections initiated in thicket rats in the laboratory show similar dynamics to primary 
infections in mice (Carter & Diggs 1977). It is not surprising that such primary 
infections have never been observed in thicket rats in the wild, given that parasite 
densities in primary infections in mice reach low levels within about 20 days (Taylor et 
at. 1997). Moreover, the complete life-cycle of P. chabaudi can be completed using 
mice and a unnatural vector of the parasite, Anopheles stephensi (Landau & Chabaud 
1994), suggesting that the mouse is not such an artificial host after all. 
The previous discussion is important because aspects of this thesis specifically deal 
with the adaptive basis of P. chabaudi life histories: this would be harder if observed 
parasite life histories were the result of a novel host-parasite association. However, it 
is also important that the parasite is not specifically adapted to laboratory conditions: it 
is necessary that the parasite is behaving as much as possible as it would under natural 
conditions. Fortunately, both clones used in this thesis (CR and ER; Beale et al. 
1978) have been exposed to a variety of mouse genotypes and transmitted by both 
mosquito and infected blood at very variable time points in the infection. Adaptation to 
particular laboratory conditions is therefore unlikely to have occurred to any large 
extent (Taylor 1997). 
P. chabaudi has advantages over other rodent malaria models. First, infections are 
rarely lethal in 'resistant' mouse genotypes (Stevenson et al. 1982). Second, 
gametocytes are produced in reasonable numbers and are readily identifiable. Third, 
the infection dynamics (Carter & Graves 1988) and parasite-immune system 
interactions (Taylor-Robinson et al. 1995) bear the closest resemblance to infections 
with the most common and virulent human malaria, P. falciparum. It is important to 
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note than speculative extrapolations from this model to human malaria are meant to 
apply only to P. falciparum in this thesis. 
P. falciparum in vitro 
Work was also carried out using P. falciparum in culture. This allowed more precise 
measurements of parasite numbers than is possible in vivo, as well as allowing 
comparison between human malaria parasites and the rodent malaria model. 
1.6 EXPERIMENTAL AIMS 
In this thesis I experimentally address the short-term (phenotypic) effects of 
chemotherapy and host immunity on the transmission and virulence of malaria 
parasites. Data from short-term effects of intervention are obviously important in their 
own right, but can also be used to make sensible speculations about longer term effects 
of these forms of intervention on parasite life histories. Moreover, most of what we 
know about the adaptive basis of life histories in free-living organisms comes from 
analogous manipulations (Stearns 1992). Antimalarial chemotherapy is still widely 
used, thus its effects on transmission and virulence are of great importance, especially 
in the light of the rapid spread of resistance to most antimalarial drugs (Peters 1987). 
The effect of host immune status on transmission and virulence are important in 
understanding epidemiology in general and also the potential effects of first generation 
vaccines (Greenwood 1997). 
The overall aim of this thesis is to determine how sub-curative chemotherapy and 
partial host immunity affect the transmission and virulence of malaria parasites. The 
specific questions addressed are as follows: 
1. Do sub-lethal (to the parasite) chemotherapy, and host immunity, induce 
gametocytogenesis? See chapters 2, 4-6. 
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Does chemotherapy and host immune status affect gametocyte infectivity? See 
chapters 3 and 5. 
How do these forms of intervention affect overall transmission? See chapters 2-6. 
How do these forms of intervention affect disease virulence? See chapter 7. 
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Chapter 2 
ADAPTIVE CHANGES IN PLASMODIUM TRANSMISSION 
STRATEGIES FOLLOWING CHLOROQUINE 
CHEMOTHERAPY 
This is a slightly edited version of Buckling et al. (1997). See Appendix. 
2.1 SUMMARY 
Both theory and data suggest that malaria parasites divert resources to the production 
of transmission stages (gametocytes) when within-host conditions deteriorate. 
Increased investment into transmission stages should therefore follow sub-curative 
treatment with antimalarial drugs, but relevant clinical studies necessarily lack adequate 
control groups. I therefore carried out controlled experiments to test this hypothesis, 
using a rodent malaria (Plasmodium chabaudi) model. Infections treated with a sub-
curative dose of the antimalarial chloroquine showed an earlier peak and a greater rate 
of gametocyte production relative to untreated controls. These alterations led to 
correlated changes in infectivity to mosquitoes. Treatment of human malaria 
commonly does not result in complete parasite clearance. If surviving parasites 
produce compensatory increases in their rate of gametocyte production, such treatment 
may have minimal effect on decreasing, and may actually increase, transmission. 
Importantly, if increased investment in transmission is a generalised stress response, 
the effect might be observed following a variety of antimalarial treatments, including 
other drugs and potential vaccines. Similar parasite life-history counter-adaptations to 
intervention strategies are likely to occur in many disease-causing organisms. 
2.2 INTRODUCTION 
Strategies of resource allocation which maximise fitness can differ between benign and 
stressful environments. Consequently, natural selection often favours phenotypic 
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alteration of reproductive effort in response to stress (Minchella & LoVerde 1981, 
Crowl & Covich 1990, Stearns 1992, Roff 1992). In disease-causing organisms, 
such adaptive alterations could render intervention strategies against parasitic diseases 
less effective than anticipated. For example, during the course of an infection, malaria 
parasites (Plasmodium spp.) are capable of modulating the proportion of replicating 
parasites (asexuals) that develop into non-replicating transmission stages 
(gametocytes). If this modulation is stress-induced, medical interventions such as 
chemotherapy could lead to greater investment in gametocyte production, thus 
offsetting much of the transmission-reducing benefits of killing parasites. Here I test 
this idea experimentally using a rodent malaria-mouse model. 
Extrapolating from metazoan life-history studies, there are two reasons to expect that 
malaria parasites will switch investment from asexuals to gametocytes when conditions 
deteriorate. First, increased reproductive effort should occur following cues 
associated with decreased probability of future survival or reproduction. For example, 
enhanced egg-production has been demonstrated in snails following exposure to 
castrating trematode infections (the 'fecundity compensation' hypothesis; Minchella & 
Loverde 1981). Increased investment by malaria parasites into gametocytes should 
therefore occur in response to environmental cues associated with the decline in future 
transmission potential, such as clearance of the infection or the onset of transmission-
blocking immunity (Koella & Antia 1995, Taylor & Read 1997). Second, if 
conditions change such that one life-history stage becomes relatively more vulnerable 
than another, increased investment into the least vulnerable stage is predicted (the 'safe 
harbour' hypothesis; Shine 1978). In the Jerusalem artichoke (Helianthus tube rosus 
L.), for example, inhibition of sexual reproduction by removing flowers results in 
increased investment in asexual reproduction via tuber development (Westley 1993). 
If conditions become less favourable for asexuals relative to gametocytes (for example 
as stage specific immunity develops), increased investment into transmission is again 
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predicted. 
The environmental cues which stimulate gametocyte production (gametocytogenesis) 
are poorly understood (Sinden 1983, Carter & Graves 1988, Alano & Carter 1990), 
but there is some evidence that the rate of gametocyte production increases in response 
to conditions unfavourable for asexual replication. P. falciparum (the most common 
and virulent human malaria parasite) produces more gametocytes in vitro when there is 
high density of parasitised red blood cells (Carter & Miller 1979, Brockelman 1982, 
Bruce etal. 1990). By definition, antimalarial drugs acting against blood-stage 
parasites impose considerable stress, and some also have a greater inhibitory effect on 
asexual parasites than on gametocytes. Increased gametocytogenesis following 
treatment that greatly reduces parasite numbers is therefore to be expected. However, 
here the evidence is more ambiguous. 
Early in vivo clinical trials with human Plasmodium frequently reported more 
gametocytes following treatment with drugs inhibiting folate-metabolism and hence 
DNA-synthesis (e.g. paludrine, pyrimethamine and the sulphonamides; Findlay et al. 
1946, Mackerras & Ercole 1948, Shute & Maryon 1951, Foy & Kondi 1952, 
Ramakrishnan etal. 1953, McCarthy & Clyde 1973). More recently, increased 
gametocyte production has also been reported in P. falciparum infections following 
treatment with Fansidar, a synergistic combination of pyrimethamine & sulphadoxine 
(Tin & Nyunt-Hlaing 1984, Marwoto etal. 1986). However, these increases occurred 
more rapidly than the 8-10 day maturation period of P.falciparum gametocytes 
(Smalley 1976, Jensen 1979), and other studies using Fansidar with longer follow up 
periods do not support the hypothesis (Strickland et al. 1986, Hogh et al. 1995). With 
other blood-stage antimalarials, such as chloroquine or quinine, most clinical studies 
have found no increases in gametocytogenesis following sub-curative treatment (e.g. 
Mackerras & Ercole 1949a, Jeffery et al. 1956, Jeffery 1958, Hogh et al. 1995). 
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These data have given rise to the conventional wisdom that only drugs that inhibit 
DNA synthesis are capable of inducing increased gametocytogenesis (Carter & Graves 
1988, Alano & Carter 1990), even though there may be exceptions (Mackerras & 
Ercole 1949b). 
But all these data have a common problem: chemotherapy may have been used when 
increases in gametocyte production would have occurred anyway. This is particularly 
likely if the conditions stimulating both gametocytogenesis and symptoms (and hence 
treatment) approximately coincide, as would be the case if, for example, high parasite 
densities or host stress were a common trigger. Understandably, no studies included 
appropriate untreated control infections, so that the effect of sub-curative antimalarial 
chemotherapy on gametocyte production has yet to be resolved. 
If enhanced gametocytogenesis can occur following sub-curative treatment, reductions 
in infectivity might not be nearly as great as reductions in morbidity. This may have 
implications for malaria control and epidemiology, particularly if increased 
gametocytogenesis is a generalised stress response stimulated by a variety of 
treatments. I therefore carried out controlled experiments using a P. chabaudi-mouse 
model to test the life-history prediction of increased gametocytogenesis following sub-
curative chloroquine chemotherapy, and to determine any impact on subsequent 
infectivity to a mosquito vector. Chloroquine (CQ) was used because of its wide 
availability in malaria-endemic areas and the general view that its use does not result in 
increased gametocytogenesis (Carter & Graves 1988, Alano & Carter 1990). In 
addition, it only affects asexual parasites and immature gametocytes (Smalley & 
Sinden 1977), 50 that increased gametocytogenesis might be expected on account of 
both the fecundity compensation and safe-harbour hypotheses. 
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2.3 MATERIALS AND METHODS 
Parasites & hosts 
Male C57/BL/6J mice (Harlan-Olac, England) aged 8-14 weeks were infected with 
lx 106 red blood cells infected with a CQ-naive P. chabaudi clone (either CR or ER, 
from the WHO Registry of Standard Malaria Parasites maintained at the University of 
Edinburgh, U.K.) in a 0.1 ml intra-peritoneal inoculum of 50 % ringer's solution (27 
mM KCI, 27 m CaC12, 0.15 M NaCl), 45% heat-inactivated calf serum and 5% 
200 units / ml heparin solution. Mice, age-matched within experiments, were housed 
in cages of 2-4 animals at a temperature of 25±1 °C with a 0700 to 1900 hours light 
cycle, and provided with 4 1 B rat and mouse maintenance diet (Harlan-Tekiad, 
England) and water containing 0.05 % pABA, ad libitum. 
CQ preparation and administration 
CQ solution was prepared from a stock of 40 mg / ml CQ sulphate (NivaquineTM) 
diluted in distilled water and administered orally using a lubricated catheter in 
approximately 0.1 ml doses of 12 mg / kg of mouse weight in all cases. Preliminary 
experiments revealed this dose to be sub-curative. Control mice were given 0.1 ml 
distilled water. All treatment took place between 1600 and 1700 hours. 
Parasite counts 
From day 4 post-infection (p.i.), daily thin blood smears from the tail vein were 
Giemsa-stained and asexual parasites accurately counted per 1.5 x 103  red blood cells 
(RBCs). At low asexual densities parasites were counted per 104  RBCs. Mature 
gametocytes were counted per 1.25 x 10 4 RBCs. Parasite densities were calculated 
from RBC densities, measured by flow cytometry (Coulter ElectronicsTM) every 
second day, multiplied by parasites per RBC. 
Mosquito feeds & dissections 
Mice were anaesthetised by an intra-muscular injection of 0.5 ml per 20 g mice 3:2:1 
distilled water: VetalarTM: RompunTM, and placed onto pots covered with nylon mesh 
containing -40 4-5 day old female Anopheles stephensi, which had been starved for 
the previous 24 hours. Mosquitoes were left to feed in the dark for 30 minutes, 
between 1845 and 1945 hours. After removal of unfed mosquitoes, the remainder 
were subsequently maintained at 25-30 °C, 70-80 % humidity, with a 12 hour light 
cycle and provided with 5 % glucose, 0.05 % pABA solution ad libitum. After 8-9 
days, approximately 25 mosquitoes per mouse were dissected to determine the 
presence of oocysts on midguts. 
Experiments 
Details of individual experiments are shown in table 2.1. In experiments 1, 2 and 4, 
infectivity was assayed by exposing half the mice in each experimental group to 
mosquitoes on day 12 p.i., and the other half on day 14 p.i. Preliminary experiments 
and other data (Taylor et al. 1997) showed that infectivity peaks during this period. 
Experiment 	Clone 	Day p.i. of 	No. mice infected 
CQ treatment CQ Control 
1 	 CR 6 6 	5 
2 	 CR 5 6 	5 
3 	 CR 4 5 
5 6 	6 
6 5 
4 	 ER 5 6 	6 
Table 2.1: Details of experiments. p.i., post-infection; CQ, chioroquine 
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Statistical analysis 
Comparisons of control and CQ-treated infections, which for the most part involve 
repeated measures on the same infections, were made using univariate analyses of the 
following summary measures for each infection. 
Total asexuals. This was estimated from parasite densities between days 8-16 p.i. 
Parasite densities prior to day 8 were not used because it was unclear whether parasites 
in the CQ-treated groups were dead or alive at the time of the smear, and by day 18 
p.i. parasite densities were at very low levels. Estimates of total parasites between 
these days were obtained by integrating under the parasite density through time curves 
for each infection. This is a reasonably accurate measure of total numbers of asexuals 
(between days 8-16 p.i.) because the asexual cycle of P. chabaudi is known to be 24 
hours (reviewed in Cox 1988). 
Total gametocytes. Gametocytes of P. chabaudi take approximately two days to 
mature (Buckling et at. unpublished, Gautret et al. 1997). An index of the total 
number of gametocytes produced by asexuals between 8 and 16 days p.i. was 
therefore obtained by integrating under the gametocyte density through time curves 
between days 10-18 p.i. This measure is not a direct estimate of total gametocyte 
numbers because gametocyte longevity is uncertain, though the data presented below 
suggests few survive longer than 24 hours. However, the sum of the gametocyte 
densities on each day is likely to be a well correlated with total transmission 
probability: gametocyte densities at any point in time correlate with both the proportion 
of mosquitoes infected and densities within mosquitoes (Taylor & Read 1997). 
Proportion of gametocytes. This was calculated as the proportion of total 
parasites [(1)+ (2)] that were gametocytes [2] for each infection. 
Day of peak gametocyte density. 
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(5) The proportion of mosquitoes infected. 
Prior to analysis, estimates of total asexuals and total gametocytes were log 10- 
transformed and proportion of gametocytes square-root arcsin-transformed to bring 
their distributions close to normal. All analyses were carried out using generalised 
linear models (GLIM; Crawley 1993). The effects of CQ treatment on total asexuals, 
total gametocytes and proportion of gametocytes were analysed by 2-way ANOVA, 
with treatment (CQ+, CQ-) and experiment (1-4) fitted as factors. The effect of CQ on 
the day of peak gametocyte density was analysed separately for each clone by 
ANOVA. For clone CR, treatment and experiment (1-3) were fitted as factors, and for 
clone ER, only treatment was fitted, as this clone was used in experiment 4 only. For 
all 2-way ANOVAs, the interaction term was incorporated into the error term if it 
expalined a non-significant amount of deviance (p  <0.05; Crawley 1993). 
A binomial error structure, applying William's correction for over-dispersion, was 
used for the logistic regression of infection probability (Crawley 1993). Starting with 
the highest order interactions, all factors (experiment (1,2 & 4), treatment and day of 
mosquito feed (12 or 14)) and their interactions were individually removed in turn 
from the complete model. Non-significant terms were removed and significant test 
statistics obtained from the resulting minimal model. 
2.4 RESULTS 
Total asexuals and total gametocytes did not differ between experiments (table 2.2). 
CQ treatment however had a significant effect, reducing asexuals to 20 % of controls 
and gametocytes to 50 % (figures 2.1 & 2.2, table 2.2). The effect of CQ did not 
differ between experiments (table 2.2). 
The proportion of gametocytes was about 2.5 times greater in CQ-treated infections 
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than in control infections (table 2.2). There were no differences between experiments, 
nor did treatment effects differ between experiments (table 2.2). Figure 2.3 shows the 
relationship between total gametocytes and total asexuals for all infections. 
mean (s.e.) 
Control 	CQ 
Total asexuals (xl 
Treatment 
Experiment 
Treat. x Exp. 
F152 	114, p <0.001 
F352 = 0.67, n.s. 
F349 = 1.26, n.s. 
2.1 (0.18) 	0.45 (0.05) 
Total gametocytes (x10 7 
Treatment F152 = 7.1, p = 0.01 
Experiment F352 = 0.44, n.s. 
Treat. x Exp. F349 = 1.87, n.s. 
Proportion gametocytes 
Treatment 17 152 = 16, p  <0.001 
Experiment F352 = 0.76, n.s. 
Treat. x Exp. F349 = 1.54, n.s. 
1.14 (0.15) 	0.67 (0.09) 
0.007 (0.001) 0.02 (0.003) 
Table 2.2: Results of ANOVA for the major summary measures. The treatment by 
experiment interaction was not significant in all cases, and was incorporated into the 
error term to determine F-ratios of factor effects. n.s.; non-significant. 
Peak gametocyte densities occurred approximately 2 days earlier in CQ-treated 
infections than in control infections for the experiments using CR (figures 2.2a-c, table 
2.3) and 3 days earlier in the experiment using ER (figure 2.2d, table 2.3). For 
experiments 1-3, the effect of treatment on timing of peak gametocyte densities did not 
differ between experiments (table 2.3), but the timing of peak gametocyte densities 
differed between experiments (table 2.3). This was probably due to differences in 
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timing of CQ treatment between experiments: there was no significant difference 
between experiments when CQ-treated groups were separated on the basis of specific 
day of treatment (p > 0.25 for controls and days 5 & 6 p.i. CQ treatment). 
Interestingly, there was a significant positive relationship between the day of CQ 
treatment and the day of peak gametocyte density for the days 4, 5 & 6 p.i. CQ-treated 
groups in experiments 1-3: (ordered heterogeneity test (Rice & Gaines 1994): rsPc = 
0.96, p  <0.01). 
There was no difference in total gametocytes between the day 4, 5 & 6 p.i. CQ-treated 
groups in experiment 3 (172,13 = 0.20, p = 0.83). The proportion of gametocytes 
however significantly differed between the groups (F2,13 = 4.38, p = 0. 035); pair- 
wise comparisons revealed the proportion of gametocytes to be greater in day 6 p.i. 
CQ-treated infections than in those treated on day 4 p.i. but there were no other 
significant differences (scheffe analysis p = 0.04, p > 0.2 for both other 
comparisons). 
Clone used 
CR 	 ER 
Treatment 	F 141 = 54.9, p <0.001 	17 110 = 19.9, p < 0.01 
Experiment F241 =4.46, p < 0.05 
Treat. x Exp.F 239 = 0. 15, n.s. 
Table 2.3: Results of ANOVA for day of peak gametocyte densities, which were 
between 2 and 3 days earlier in CQ-treated infections. The interaction term for clone 
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Figure 2.1: Mean asexual parasite densities (+ 1 s.e.) during infections for 
experiments 1 -4 (a-d respectively). CQ, chioroquine 
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Figure 2.2: Mean gametocyte densities (+ 1 s.e.) during infections for experiments 
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Figure 2.3: Total asexuals and total gametocytes (between days 8-16 and 10-18 p.i., 
respectively) for all chioroquine-treated and untreated infections in experiments 1-4. 
Proportions of mosquitoes infected were greater in CQ-treated mice than control mice 
on day 12 p.i. and vice versa on day 14 p.i. (figure 2.4, table 2.4). There were no 
significant differences in overall proportion of mosquitoes infected between 
experiments, day and treatment, and neither treatment or day effects, and their 
interaction, differed between experiments (table 2.4). 
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Day of mosquito feed 
	
0.8 
Treatment x day 	 1.2 	n. s. 
Table 2.4: Minimal model for logistic regression of mosquito infection probability. 
Experiment and the other interactions were removed from the model as they did not 
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Figure 2.4: Mean proportions of mosquitoes infected (±1 s.e.) for chloroquine-
treated and untreated mice on days 12 & 14 post-infection 
2.5 DISCUSSION 
Infections treated with CQ produced significantly fewer asexuals and gametocytes than 
untreated infections, but for a given number of asexuals, the number of gametocytes 
was about 2.5 times greater in CQ-treated infections. This is most likely the result of 
increased gametocytogenesis following sub-curative CQ treatment, consistent with the 
hypothesis. 
Changes in the relative mortality rates of gametocytes and asexuals can not adequately 
explain the results. First, stage-specific mortality caused by CQ can not be involved. 
The half-life of whole-blood CQ-concentration in mice heavily infected with P. 
chabaudi (21-25 % parasitised RBCs) is in the order of 7 hours (Cambie et al. 1994). 
Parasite numbers were first assayed at least two days after treatment, when the CQ 
level must have been less than 0.5 mg / kg; preliminary experiments revealed twice this 
concentration to have no noticeable effect on parasite numbers or infection dynamics. 
Moreover, virtually all the gametocytes counted must have been produced from post-
treatment asexuals: any long-lived gametocytes present during the period of CQ 
activity would have made up only a tiny fraction of the gametocytes used to estimate 
subsequent gametocytogenesis because they were at such low densities when 
infections were drug-treated (figure 2.2). Second, differential mortality resulting from 
differences in immune response between the groups not only requires a gametocyte-
specific clearance mechanism, for which there is currently no evidence (Taylor & Read 
1997), but also one which is suppressed by CQ. 
The best explanation for the relative increase in numbers of gametocytes following CQ 
treatment is therefore increased gametocytogenesis, as predicted by both the safe 
harbour and the fecundity compensation hypotheses. Nevertheless, the delay between 
CQ treatment (hence peak asexual density) and gametocyte production (figures 2.1 & 
2.2) is not entirely consistent with these adaptive hypotheses. Increased 
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gametocytogenesis in response to stress might be expected to be immediate, resulting 
in mature gametocytes 2-3 days later. Instead, we observed a delay of about a week. 
However, it is striking that in control infections there is also a delay of approximately a 
week between peak asexual density and peak gametocyte density. An intriguing 
possibility, consistent with the hypotheses, is that a sudden drop in parasite numbers 
might be acting as the cue for delayed gametocytogenesis in both CQ-treated and 
control mice. In untreated mice, such a strategy might have the function of minimising 
production of gametocytes during crisis, an immune mediated response associated 
with anaemia which down regulates parasite numbers (Jarra & Brown 1989) and 
during which gametocyte infectivity is greatly suppressed (Wery 1968). It is feasible 
that CQ treatment results in an artificially early occurrence of the same cue that 
stimulates this crisis-avoiding delay. 
Gametocytogenesis frequently follows a substantial reduction in overall parasite 
numbers (Sinden 1983, Carter & Graves 1988, Alano & Carter 1990, Sinden et al. 
1996, figures 2.1 and 2.2), suggesting a positive relationship between 
gametocytogenesis and factors that correlate with parasite destruction. Such factors 
might explain how gametocytogenesis was triggered in control and CQ-treated 
infections despite radically different parasite dynamics (figures 21 and 2.2) and host 
condition in the two groups. Increased relative gametocytogenesis following CQ 
treatment might be explained by the resulting short-term very high rate of parasite 
destruction. This relationship would also explain why gametocytogenesis was greater 
in mice treated with CQ on day 6 p.i. compared with day 4 p.i. The later treatment 
inevitably resulted in greater parasite death, both because by that stage there were more 
for CQ to kill (figure 2. lc), and because of enhanced immune activity as a result of 
greater exposure, in terms of both time and numbers, to parasite antigens. 
Whatever the mechanism involved, these results clearly demonstrate increased 
gametocytogenesis following sub-curative CQ treatment. As far as I am aware, this is 
the first fully controlled demonstration that sub-curative treatment with an antimalarial 
drug can increase gametocytogenesis in Plasmodium, and thus alter patterns of 
infectiousness. The dose of CQ used in this study is equivalent to half the commonly 
recommended dose for treatment of people with P. falciparum (25 mg / kg over three 
days; Desjardins et al. 1988). Because of treatment terminating following clinical 
improvement, and the high frequency of drug-resistant parasites, sub-curative 
treatment often occurs (Wernsdorfer 1994). The results are therefore potentially 
relevant to the treatment of Plasmodium with CQ in the field. First, even large 
reductions in the numbers of asexual parasites may have a much less dramatic effect on 
infectivity because of compensatory investment into gametocytes. It is notable that in 
our transmission experiments, the proportion of mosquitoes infected were similar from 
treated and untreated infections (figure 2.4). Second, transmission between hosts 
might actually be faster where sub-curative treatment is common, because of the earlier 
timing of peak infectivity (figure 2.4). Transmission may be further enhanced by the 
general reduction in host immunity because of decreased exposure to the parasite 
(Graves et al. 1988) and by the increased infectiousness of gametocytes apparently 
induced by very low level CQ treatment (Ramkaran & Peters 1969, Wilkinson et al. 
1976, Ichimori et al. 1990). Finally, if the effect is a generalised stress-response, it 
might be observed following treatment with most blood-stage antimalarials and even 
potential vaccines. 
Here I have only considered phenotypic modifications of gametocytogenesis. 
Consistent differences in gametocyte production between isolates of P. falciparum in 
vitro (Burkot et al. 1984, Graves et al. 1984) may imply natural genetic variation in 
gametocytogenesis on which drug-imposed selection could act to generate long-term 
changes in resource allocation between asexuals and gametocytes. Parasites will 
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probably increase their fitness under drug pressure by producing gametocytes in 
greater quantities earlier in the infections. Lines et al. (199 1) suggested that just such 
adaptation may underlie increases in malaria transmission in Tanzania following long-
term CQ use. This is supported by a recent study in Sri Lanka which showed that 
infections of CQ-resistant parasites are more likely to be gametocyte positive than 
infections caused by sensitive parasites (Handunnetti et al. 1996): under drug 
pressure, adaptive life-history changes are likely to evolve in parallel with the 
development of drug resistance. Both short- and long-term parasite life-history 




THE EFFECT OF CHLOROQUINE TREATMENT ON THE 
INFECTIVITY OF PLASMODIUM CHABAUDI 
GAMETOCYTES 
3.1 SUMMARY 
The antimalarial drug, chioroquine (CQ), has been reported to increase the infectivity 
of the forms of blood-stage malaria parasites (gametocytes) that are capable of 
infecting mosquito vectors. This effect has been convincingly demonstrated in the 
short-term (12 hours post treatment), although several authors have suggested 
infectivity enhancement a week or more after treatment. I carried out experiments to 
investigate the effects of CQ on the longer term infectivity of gametocytes of the rodent 
malaria parasite, Plasmodium chabaudi, to Anopheles stephensi mosquitoes. 
Gametocytes of CQ-treated infections were significantly more infectious than untreated 
infections 6 and 7 days post treatment, although not on days 8 and 9. However, this 
effect was most likely the result of a reduction in infectivity in untreated infections, 
caused by immune activity which was not so pronounced in CQ-treated infections. 
Gametocytaemia (gametocytes / red blood cell) showed a strong positive and linear 
relationship with infectivity. Infectivity was not influenced by either asexual 
parasitaemia, asexual density or anaemia. Parsimonious interpretations of the effect of 
CQ on gametocyte infectivity are discussed. 
3.2 INTRODUCTION 
Antimalarial chemotherapy has frequently failed to significantly reduce malaria 
prevalence, and resistance to many antimalarial drugs has spread at an alarming rate 
(Butcher 1997). This is partly because some of the commonly used antimalarial drugs 
have little parasite killing activity against the transmission stages of a Plasmodium 
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infection, gametocytes (Smalley & Sinden 1977, Klein etal. 1991). However, two 
other mechanisms by which chemotherapy might enhance transmission have been 
suggested. First, chemotherapy may induce greater gametocyte production, both 
through genotypic (Bishop 1954, Lines etal. 1991, Handunnetti etal. 1996) and 
short-term phenotypic changes (Buckling etal. 1997, chapter 2). Given the generally 
positive correlation between gametocyte densities and infectivity to mosquitoes (Carter 
& Graves 1988, Taylor & Read 1997), such changes are likely to increase 
transmission. Second, the antimalarial drug chloroquine has been reported to increase 
the infectiousness of gametocytes, independent of gametocyte densities (Butcher 
1997). 
Data on infectivity enhancement of gametocytes by chloroquine is ambiguous. It is 
clear that CQ per se does not increase gametocyte infectivity: the addition of CQ to 
cultures prior to feeding mosquitoes did not increase either the proportions of 
mosquitoes infected, or the number of parasites (oocysts) that subsequently developed 
(Chutmongkonkul et al. 1992, Rosario et al. 1988, Butcher 1997). Enhanced 
gametocyte infectivity 12 hours post sub-curative chioroquine (CQ) treatment has been 
demonstrated in vivo for the rodent malaria parasites Plasmodium yoe!!i (Ramkaran & 
Peters 1969, Hamidi 1977) and P. y. nigeriensis (Ichimori etal. 1990). However, 
there was no reported increase in the infectivity of P. falciparum gametocytes when 
mixed with sera collected 24 hours after CQ had been taken, compared with sera 
before treatment (Ponnundurai et al. 1989). Similarly, there was no infectivity 
enhancement of P. vivax in human volunteers between 0 and 72 hours post-treatment 
(Klein et al. 1991). 
There has been suggestions that CQ can enhance per gametocyte infectivity a week or 
more after treatment, but here the data are even more ambiguous. Curative CQ-
treatment of P. falciparum-infected humans resulted in greater median parasite burdens 
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in Anopheles balabacensis mosquitoes (but not in A. dirus) fed 2 & 7 days after 
treatment, compared to before treatment. However, mean oocyst burdens and the 
proportions of mosquitoes infected did not change (Wilkinson et al. 1976). Hogh et 
al. (1998) recently reported that 'serum from chloroquine-treated, uninfected, non-
immune volunteers enhanced gametocyte infectivity with increasing efficiency for 21 
days following treatment', using cultured gametocytes of P. falciparum and of the 
rodent malaria, P. berghei. They report a significant increase in infectivity through 
time following CQ treatment with P. berghei gametocytes, and a non-significant 
increase with P. falciparum gametocytes. Infectivity of gametocytes obtained from 
naturally infected CQ-treated volunteers was not significantly greater when mixed with 
the patients own (CQ-containing) plasma compared to European control plasma (Hogh 
et al. 1998). A field study investigating factors influencing human infectivity to 
mosquitoes also found no P. falciparum infectivity-enhancing effects of CQ 
(Tchuinkam et al. 1993). 
It is clearly important to determine whether CQ enhances gametocyte infectivity for 
more than a matter of hours. I therefore carried out experiments to investigate 
gametocyte infectivity of the rodent malaria, P. chabaudi, in vivo 6 to 9 days after CQ-
treatment, at the time of peak gametocyte production. 
3.3 MATERIALS AND METHODS 
Parasitology 
Details of methodology are given in chapter 2. Male C57/BL/6J mice were infected by 
intra-peritoneal inoculation with 106  parasites on day 0. Parasite clones and sample 
sizes are shown in table 3.1. On day 5 or 6 post infection (p.i.; 1 to 2 days before the 
average peak asexual parasite density (Buckling et al. 1997, chapter 2)), half the mice 
were orally treated with a sub-curative dose of chioroquine sulphate (12 mg / kg); the 
others received distilled water (controls). On day 12 and 14 p.i. (the days of peak 
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gametocyte densities in CQ-treated and untreated infections, respectively (Buckling et 
al. 1997, chapter 2)), half the mice from each experimental group were anaesthetised 
and fed to -40 4-5 day old A. stephensi. Asexual parasites and gametocytes per red 
blood cell (RBC) and RBC density were determined on both feed days; parasite 
densities were calculated from the product of these variables. Approximately 25 
mosquitoes per mouse were dissected 8-9 days after feeding and the number of 
parasites (oocysts) on their midguts determined. 
Experiment 	Clone 	Day p.1. of 	No. mice infected 
CQ treatment CQ Control 
1 CR 6 6 5 
2 CR 5 6 6 
4 ER 5 6 6 
Table 3.1: Details of experiments. p.i., post-infection; CQ, chloroquine 
Statistical analyses 
All analyses were carried out using GUM 4. Proportions of mosquitoes infected per 
mouse were analysed by logistic regression with a binomial error structure. Over-
dispersion in the data was corrected by using a heterogeneity factor (HF) of 3.05, 
determined from the ratio of Pearson's x2  to the degrees of freedom in the minimal 
model (Crawley 1993). Day p.i. of feed (12 or 14), treatment (CQ+, CQ-) and 
experiment (1,2 or 3) were fitted as factors, and angular-transformed gametocytes / 
RBC (gametocytaemta) fitted as a covariate. The minimal model was determined by 
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stepwise deletion, starting with the highest order interactions, with non-significant 
terms discarded (Crawley 1993). The explanatory power of remaining terms was 
determined by deletion from the minimal model. Additional covariates (log 10-
transformed gametocyte densities, asexual densities and RBC densities, and angular-
transformed asexuals / RBC (asexual parasitaemia)) were substituted with 
gametocytaemia in the minimal model to determine if they explained a significant 
amount of additional deviance. 
Further analyses were carried out in the same way within days (HF = 3, 3.6 for days 
12 & 14 p.i., respectively) and treatments (HF = 1.8, 4.1 for CQ+ & CQ-, 
respectively), using only covariates that were significant in the previous model. 
Analyses of oocyst burdens were also carried out within days and treatments using a 
negative binomial structure, with the over-dispersion parameter, k, estimated 
separately within each analysis (Crawley 1993, Wilson & Grenfell 1997). Data from 
individual mosquitoes were nested within mouse to avoid psuedo-replication. Non-
significant interactions were combined with the error term to determine significance of 
main effects. Differences in (1og 10-transformed) gametocyte densities between days 
and treatments were determined by ANOVA, using stepwise deletion as above, with 
treatment, day and experiment fitted as factors. 
3.4 RESULTS 
Gametocyte densities were 3.8 times higher on day 12 p.i than day 14 p.i. in CQ-
treated infections, and 4.4 times higher on day 14 p.i. than day 12 p.i. in untreated 
infections (figure 3. 1, day by treatment interaction: F 129 = 5.03, p  <0.05). In the full 
logistic regression model, gametocytaemia explained 46 % of the deviance associated 
with proportions of mosquitoes infected (figure 3.2, table 3.2), which was 
significantly greater than the deviance explained by gametocyte density (difference 
between gametocytaemia and gametocyte density: x21 = 4.87, p  <0.05). The 
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relationship between (untransformed) gametocytaemia and proportion of mosquitoes 
infected was approximately linear (figure 3.2); allowing the best fit regression to 
curve, by the addition of the quadratic function, did not explain significantly more 
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Figure 3.1: Mean ± 1 s.e. gametocyte densities in CQ-treated and untreated 
infections on days 12 & 14 post infection. 
To determine the effect of CQ on per gametocyte infectivity, gametocytaemia had to be 
controlled for. When this was done, the effect of CQ-treatment on proportions of 
mosquitoes infected differed on days 12 and 14 p.i. (table 3.2). No main effects of 
the factors (day, experiment or treatment), covariates (gametocyte, asexual and RBC 
densities, and asexual parasitaemia) or their other interactions explained a significant 
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Figure 3.2: Relationship between proportion of mosquitoes infected and 
gametocytaemia (gametocytes / 1000 RBCs) for all data (35 mice). Some points are 
multiple data points. 
X 2 1 	 p 
Gametocytaemia 25.12 	<0.001 
Day of mosquito feed 0.74 n. s. 
Treatment 0.95 	n. s. 
Day x treat. 4.19 <0.05 
Table 3.2: Minimal model for logistic regression of mosquito infection probability. 
Experiment, additional covariates and the other interactions were removed from the 
model as they did not explain a significant amount of deviance (p > 0.1). n.s.; non- 
significant. 
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Because of the significant treatment by day interaction in the full model, data were 
separately analysed within days and treatments. When the data from only day 12 p.i 
was analysed, infectivity per gametocyte was 3.2 times greater (at the mean 
gametocytaemia) in CQ-treated than untreated infections (figure 3.3a, table 3.3). Mean 
oocyst burdens (per gametocyte) were 3.1 times greater (at the mean gametocytaemia) 
in CQ-treated compared to untreated infections (table 3.3). Neither proportions of 
mosquitoes infected or mean oocyst burdens (per gametocyte) on day 14 p.i. differed 
between CQ-treated and untreated infections (figure 3.3b, table 3.3). 
Proportion infected 
Day 12 	Day 14 
Gametocytaemia X 




2 1=  43* X 21 = 0.56 
Experiment X 
2 = 0.5 X 
2 = 1.48 
Gam. x exp. 
mean+s.e. control 	0.065+0.03 0.22+0.1 
mean+s.e. CQ 0.21+0.05 	0.20+0.09 
Oocyst burdens 
Day 12 	Day 14 
F 110  = 88.6** F 113  = 27.8** 
F110  = 12.1** F 113 = 1.8 





Table 3.3: Minimal models for logistic regression of proportion of mosquitoes 
infected and negative binomial analysis of oocyst burdens on days 12 and 14 p.i.; non-
significant interactions were removed from the model. *p  <0.05;  **p  <0.01. 
Arithmetic mean (+ 1 s.e.; corrected for error distribution) oocyst burdens, 
proportions of mosquitoes infected at the mean gametocytaemia (= 0.35 gametocytes / 
1000 RBCs) are shown for CQ (chloroquine)-treated and control infections 
When only untreated infections were considered, the proportion of mosquitoes 
infected and mean oocyst burdens (per gametocyte) were, at the mean gametocytaemia, 
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respectively 3.4 and 2.9 times greater on day 14 p.i. than day 12 p.i. (figure 3.3c, 
table 3.4). However, within CQ-treated, gametocyte infectivity as measured by both 
proportions of mosquitoes infected and mean oocyst burdens, did not differ between 
days 12 & 14 p.i. (figure 3.3d, table 3.4). 
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Figure 3.3: Relationship between logit-transformed proportions of mosquitoes 
infected and square-root arcsin-transformed gametocytaemia. Lines show ordinary 
least square regressions from statistical models. Legends in bold correspond to solid 
symbols. Small numbers in body of figures represent multiple data points. (a) data 
from day 12 post-infection (p.i.). (b) data from day 14 p.i. (c) data from all untreated 
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2 1=  79* X21 = 0.2 
X 22 = 0.7 X 2 = 0.2 
F1,12 :_ 112 = 30.3**  F111  = 12.9** 
F112  = 10.9** F 111 = 1.33 
F212 = 1.8 	17 111 = 0.5 
F2,11 2, 1 - 
Table 3.4: Minimal models for logistic regression of proportion of mosquitoes 
infected and negative binomial analysis of oocyst burdens for control and CQ-treated 
infections; non-significant interactions were removed from the model. 	<0.05; **p 
<0.01. 
3.5 DISCUSSION 
Gametocytaemia was the best predictor of infectiousness in this study (figure 3.2), but 
did CQ enhance per gametocyte infectiousness? On day 12 p.i., gametocytes in CQ-
treated mice were more infectious than those in untreated infections (figure 3.3a), both 
in terms of proportion of mosquitoes infected and mean oocyst burdens. Two days 
later, any effects of CQ on gametocyte infectivity were no longer detectable (figure 
3.3b). These data can be interpreted in two ways. First, CQ enhanced infectivity on 
day 12 p.i., but the effect was lost by day 14 p.i. Second, infectivity was suppressed 
on day 12 p.i. in untreated infections, but not on day 14 p.i. That infectivity was 
greater on day 14 p.i. than day 12 p.i. in untreated infections (figure 3.3c), but there 
was no difference in infectivity between days in CQ-treated infections (figure 3.3d), 
leads to acceptance of the latter hypothesis. Thus, any effect of CQ on infectivity was 
not direct. 
The reduction in infectivity in untreated infections relative to CQ-treated infections on 
day 12 p.i. is consistent with the infection dynamics. In untreated infections a 
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phenomenon called 'crisis' occurs. This is a rapid reduction in parasite numbers 
associated with low RBC densities and strong immune activity (Jarra & Brown 1989), 
during which gametocyte infectivity is suppressed (Wery 1968, and see Carter et al. 
1997 for a related phenomenon in the human malaria parasite, P. vivax). Crisis 
occurred between days 8-10 p.i. in untreated infections in these experiments, and it is 
entirely plausible that gametocyte infectivity-suppressing 'crisis factors' are still 
present by day 12 p.i., but not day 14 p.i. Crisis did not occur in CQ-treated 
infections because of the greatly reduced peak asexual parasite densities (Buckling et 
al. 1997). 
In untreated infections, reduced gametocyte infectivity on day 12 p.i. was also 
associated with low gametocyte densities. There was a similar pattern on day 14 p.i. 
in CQ-treated infections (figures 3.1 & 3.3). The infectivity of individual gametocytes 
may therefore be a positive function of gametocyte density, as would be the case if the 
probability of gamete fusion in the mosquito midgut was considerably reduced at low 
gametocyte densities. There is however no evidence that per gametocyte 
infectiousness increased non-linearly at high gametocytaemias (figure 3.2). 
The results imply that if CQ does increase the infectiousness of P. chabaudi 
gametocytes, the effect is lost by 6-7 days post-treatment. This is before the vast 
majority of gametocytes were produced in both untreated and CQ-treated infections 
(Buckling et al. 1997, chapter 2). The plasma half-life of CQ in malaria infected mice 
is approximately 7 hours (Cambie et al. 1994), and thus would be at very low 
concentrations after 6-7 days. The current results are therefore inconsistent with the 
suggestion that long-term metabolites of CQ are responsible for the reported 
infectivity-enhancing effects of CQ (Butcher et al. 1997, Hogh et al. 1998). 
Ultimately, our data are consistent with most previously published data: there is no 
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strong evidence to suggest that CQ has long-term infectivity-enhancing effects on 
gametocytes. 
Infectivity enhancement by CQ has only been convincingly demonstrated in the short-
term (12 hours post-treatment), in controlled experiments using rodent malaria 
parasites in vivo (Ramkaran & Peters 1969, Hamidi 1977, Ichimori et al. 1990). A 
plausible explanation for these data is an immunosuppressive effect of CQ. CQ is 
known to inhibit antigen processing and presentation (Fox & Kang 1993), and 
leukocyte function in general (reviewed in Targett 1992a). Such mechanisms could 
conceivably reduce anti-gametocyte immune activity, resulting in increased gametocyte 
infectivity in the short term. Infectivity enhancing effects would be expected to last 
only as long as CQ (or the major antimalarial metabolite, desethyl-CQ) were at 
sufficient concentrations to have an immunosuppressive effects. Infectivity 
enhancement would be expected to increase with CQ dose, up to a point where 
growing gametocytes were being destroyed - mature gametocytes are unaffected by 
CQ (Smalley & Sinden 1977). This prediction is supported by intermediate doses of 
CQ having the greatest infectivity-enhancing effect (Ramkaran & Peters 1969). 
Although a short-term immunosuppressive effect of CQ could be of potential 
importance to malaria epidemiology and the spread of drug-resistant genotypes, longer 
term effects, if they occur, would be of great significance. We find no evidence of 
such long term effects in P. chabaudi. Further work on P. falciparum is required to 
resolve this important issue. 
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Chapter 4 
INCREASED GAMETOCYTOGENESIS IN PLASMODIUM 
CHABAUDI FOLLOWING ANTIMALARIAL 
CHEMOTHERAPY 
4.1 SUMMARY 
The proportion of asexual blood-stage malaria parasites that develop into transmission 
stages (gametocytes) can increase in response to stress. I investigated whether stress 
imposed by a variety of antimalarial drugs, used sub-curatively as treatment or 
prophylaxis, increased gametocyte production (gametocytogenesis) in the rodent 
malaria parasite, Plasmodium chabaudi, in vivo. All methods of chemotherapy greatly 
reduced the numbers of asexual parasites produced during an infection, but increased 
overall rates of gametocytogenesis: there was either no reduction in gametocyte 
densities, or a smaller reduction than experienced by asexuals. I used a simple model 
to estimate temporal variation in gametocyte production. In untreated and prophylaxis 
infections, gametocytogenesis always increased as the infection progressed, showing a 
negative relationship with asexual multiplication. Drug treatment resulted in high rates 
of gametocytogenesis earlier in the infection, resulting in earlier peak gametocyte 
densities relative to untreated infections. Given the correlation between gametocyte 
densities and infectivity to mosquito vectors, and the high frequency of sub-curative 
drug treatment and prophylaxis, these data suggest that chemotherapy may frequently 
have only a small effect on reducing malaria transmission and may help to explain the 
rapid spread of drug resistant genotypes. 
4.2 INTRODUCTION 
Mammalian malaria parasites (Plasmodium spp.) undergo cycles of asexual replication 
in red blood cells (RBCs), with a small proportion of the asexual parasites producing 
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non-replicating transmission stages, gametocytes. In vitro studies have demonstrated 
that gametocyte production (gametocytogenesis) of the human malaria parasite P. 
falciparum is upregulated in response to a variety of stimuli, most of which create 
conditions unfavourable for asexual replication (Mons 1985, Carter & Graves 1988, 
Sinden et al. 1996). If increased gametocytogenesis is a general response to 
unfavourable conditions, it may be expected following novel stresses, such as 
antimalarial chemotherapy (Buckling et al. 1997, chapter 2). 
If drugs are used in doses which kill some parasites, the survivors will inevitably 
suffer some ill effects from the drugs and may be stimulated to produce gametocytes. 
Indeed, sub-curative treatment is common (Wemsdorfer 1994), as is partially 
protective prophylaxis (drugs taken before infection), given the high proportion of 
individuals with low drug concentrations detected in blood and urine (e.g. Koella et at. 
1990, Hogh et at. 1995). Because of the generally positive correlation between 
gametocyte density and infectivity to the mosquito vector (Carter & Graves 1988, 
Taylor & Read 1997, Taylor et al. 1997, Buckling et al. 1997, chapter 2), stress-
induced gametocyte production may render antimalarial chemotherapy ineffective at 
markedly reducing malaria transmission. 
A number of clinical studies have investigated the effect of antimalarial drugs on 
gametocytogenesis in humans (reviewed in Buckling et al. 1997, chapter 2). The data 
are however necessarily ambiguous. For ethical reasons, curative drug doses were 
used. In addition, there were no untreated controls, so that any increases in 
gametocyte densities may represent the natural progression of the infection. However, 
a series of controlled experiments on the effect of treatment with the antimalarial 
chioroquine on gametocyte production in the rodent malaria, Plasmodium chabaudi, 
showed that following chloroquine treatment, the proportion of circulating parasites 
that were gametocytes was more than twice that in untreated infections, peak 
gametocyte densities occurred two days earlier and, importantly, treated infections 
were as infectious to mosquitoes as untreated infections (Buckling et al. 1997, chapter 
2). 
Here I report further investigations into chemotherapy-induced gametocytogenesis of 
Plasmodium chabaudi in vivo, which address the following issues. First, is increased 
gametocytogenesis and the earlier appearance of peak gametocyte densities in response 
to sub-curative drug treatment independent of the mode of action of antimalarial drugs? 
I used pyrimethamine, quinine & mefloquine, which have different parasite-killing 
mechanisms. Pyrimethamine ultimately inhibits DNA synthesis. The mechanisms of 
action of the other drugs are not fully understood, but, like chloroquine, they are 
believed to interfere with haemoglobin metabolism in some way (reviewed in Butcher 
1997). Second, does increased gametocytogenesis occur following different types of 
sub-lethal prophylaxis? I used pyrimethamine and chioroquine to test this. Third, 
how does gametocytogenesis temporally vary during the course of an untreated in vivo 
infection, and how is this pattern altered by chemotherapy? 
4.3 MATERIALS AND METHODS 
Parasites & hosts 
Male C57/BL/6J mice (Harlan-Olac, England) aged 8-14 weeks were infected with 
lx 106  red blood cells infected with a drug-naive P. chabaudiclone (either CR or ER 
(Beale et al. 1978), from the WHO Registry of Standard Malaria Parasites maintained 
at the University of Edinburgh, UK) in a 0.1 ml intra-peritoneal inoculum of 50 % 
ringer's solution (27 mM KC1, 27 mM CaC12, 0.15 M NaCl), 45 % heat-inactivated 
calf serum and 5 % 200 units / ml heparin solution. Mice, age-matched within 
experiments, were housed in cages of 2-4 animals at a temperature of 25±1 °C with a 
0700 to 1900 hours light cycle, and provided with 41B rat and mouse maintenance diet 
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(Harlan-Tekiad, England) and water containing 0.05 % pABA, ad libitum 
Drug preparation and administration 
Chioroquine solution was prepared from a stock of 40 mg / ml Chloroquine sulphate 
(NivaquinelM) diluted in distilled water. Quinine & mefloquine solutions were 
prepared by dissolving their hydrochlorides in distilled water, except in the cases 
where pyrimethamine (base) was used in experiments, in which case all drugs were 
dissolved in Dimethyl sulfoxide (DMSO). Drug solutions were administered orally 
using a lubricated catheter in approximately 0.1 ml volumes; doses are shown in table 
4.1. Drug treatment occurred on day 5 post-infection (p.i.) between 1600 and 1700 
hours, and prophylaxis approximately 1 hour before parasite inoculation (day 0 p.i.). 
Control mice were given 0.1 ml distilled water or DMSO, depending on the solvent 
used for the drugs in each experiment. 
Parasite counts 
Thin blood smears from the tail vein were taken approximately every second day from 
day 4 or 5 p.i., Giemsa-stained and asexual parasites counted per 1.5 x 103  red blood 
cells (RBCs). At low asexual densities parasites were counted per 10 4 RBCs. Mature 
gametocytes were counted per 1.25 x 104  RB Cs. Parasite densities were calculated 
from RBC densities, measured by flow cytometry (Coulter ElectronicsTM) every 
second day, multiplied by parasites per RBC. 
Experiments 
Details of individual experiments are shown in table 4.1. 
is 
Experiment Experimental Clone Treatment dose n 
block (mg/kg)* 
1 1 CR untreated - 5 
qu-treated 200 4 
2 2 ER untreated - 4 
qu-treated 200 4 
3 3 ER untreated - 4 
qu-treated 200 6 
1 1 CR untreated - 5 
py-treated 2 4 
3 2 ER untreated - 4 
py-treated 5 5 
5 1 CR untreated - 4 
mf-treated 9 4 
6 2 ER untreated - 4 
mI-treated 9 3 
1 1 CR untreated - 5 
py proph 1 4 
4 2 ER untreated - 6 
py proph 2 5 
4 1 ER untreated - 6 
cqproph 6 5 
5 2 CR untreated - 4 
cqproph 4 5 
6 3 ER untreated - 4 
eq proph 4 3 
Table 4.1: Details of experiments and analyses. Each 'Experiment' was carried out 
at a different time, resulting in 2 or 3 'Experimental blocks' for each method of 
chemotherapy. qu = quinine, py = pyrimethamine, mf = mefloquine, eq = 
chloroquine; proph = prophylaxis; n = number of mice. * mg / kg mouse weight. 
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Estimation of daily rates of gametocyto genesis 
I used a simple exponential growth model to estimate the proportion of asexual 
parasites that produced gametocytes on individual days (see figure 4.1). 
schizogony 	schizogony 
4!!~> 
S 	 gametocytes 
asexuals m 
time (t) 	 t+ 1 
	
t+2 
Figure 4.1: Schematic showing parameters of the model (see text). A proportion 
(g) of asexual parasites measured at time t will produce gametocytes when they reach 
maturity. Mature parasites undergo schizogony, producing m progeny. A proportion 
of parasites (s) will survive until t+ ]. Surviving asexual parasites then repeat the 
cycle. Surviving gametocytes undergo no further mortality, reaching maturity at t+2. 
The synchrony of parasite development in P. chabaudi infections (Cox 1988) 
simplifies matters. The maturation period of P. chabaudi gametocytes is 
approximately 2 days (Gautret et at. 1997), such that a proportion, g, of the asexual 
parasites at day t will produce gametocytes that will mature on day t+2. P. falciparum 
gametocytes become less vulnerable to immune and drug clearance as they mature, 
probably because they express less immunogenic antigens and have reduced metabolic 
activity (Carter & Graves 1988). Age-dependent mortality of P. chabaudi gametocytes 
is likely to be similar. It is therefore assumed that survival probability (s) in the first 
24 hours after asexual densities were measured is the same for gametocytes and 
asexuals. This period encompasses the time taken for asexual parasites to mature and 
rupture (schizogony), releasing the gametocyte or asexual progeny. Schizogony 
occurs around midnight in clones ER and CR under the employed light-dark cycle 
(McLean 1986), approximately 7 hours after parasite densities at time t were 
measured. Zero gametocyte mortality is assumed in the second 24 hour period. 
The half-life of mature P. chabaudi gametocytes is estimated to be less than 12 hours 
(A. Buckling, unpublished data), so that few mature gametocytes are likely to 
contribute to the gametocyte population of the following day. If we assume that 
asexual parasites produce m progeny parasites which develop into all gametocytes or 
asexuals (as is the case for P. falciparum; Bruce et at. 1990), the number of 
gametocytes on day t+2 (G +2) can be written as 
G+2 = sgmA7 	 (1), 
where A t  refers to the number of asexuals on day t.. 
The asexual cycle of P. chabaudi is 24 hours (Cox 1988), so that two asexual cycles 
occur during the maturation time of a gametocyte. If we assume that both asexual 
mortality, s, and the probability of an asexual parasite producing gametocytes, g , are 
constant during the two day period, the number of asexuals on day t+2 (A 2) can be 
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written as 
A,2 = s2 (1-g) 2  m 2 A 	 (2). 





We can thus estimate g from observed densities of asexuals and gametocytes. There 
are potential problems with some of the assumptions outlined above. In particular, it 
is likely that rates of gametocytogenesis (g) and survival of parasites (s) will differ 
between the two rounds of asexual replication that occur for each estimate of g. 
Values of g were generally very low (see below); differences in g between the two 
periods will thus have only a small effect on the estimates. Differences in parasite 
survival may however be very large, potentially under-estimating or over-estimating g 
when mortality is greatest during the first or second period, respectively. However, 
based on biologically feasible corrections to the assumptions, Crooks et al. (in 
preparation) demonstrate that the current estimates of gametocytogenesis are a good 
approximation, although accuracy is likely to markedly decrease towards the end of 
infections. 
Statistical analysis 
The following summary measures were determined for each infection. 
(1) Total asexuals. This was estimated from parasite densities between days 7-18 p.i. 
for drug treatment comparisons, and between days 0-18 p.i. for prophylaxis 
comparisons. Parasite densities prior to day 7 p.i. were not used for the former 
because the effects of drug treatment on gametocytogenesis would not be apparent, 
and by day 18 p.i., the vast majority of parasites had been cleared by their hosts. 
Estimates of total parasites between these days were obtained by integrating under the 
parasite density through time curves for each infection. This is a reasonably accurate 
measure of total numbers of asexuals (between the appropriate time periods) because 
the asexual cycle of P. chabaudi is known to be 24 hours (reviewed in Cox 1988). 
Total gametocytes. An index of the total number of gametocytes was estimated 
between the same time periods as for the asexual parasites by integrating under the 
gametocyte density through time curves. This measure will be reasonably accurate, as 
the half-life of gametocytes is less than 12 hours and measures were taken every 
second day. The sum of the gametocyte densities on each day is likely to be a well 
correlated with total transmission probability: gametocyte densities at any point in time 
correlate with both the proportion of mosquitoes infected and parasite densities within 
mosquitoes (Taylor & Read 1997). 
Proportion of gametocytes. This was calculated as the proportion of total 
parasites [(1)+ (2)] that were gametocytes [2] for each infection. 
Day of peak gametocyte density. 
Daily rates of gametocyto genesis. Rates of gametocytogenesis were calculated for 
all drug-treated, and the appropriate untreated infections, on days 5, 8, 10, 12 p.i., 
except where asexual densities on those days were determined to be zero. Rates were 
additionally calculated for days 14 & 16 p.i. in prophylaxis experiments, when, unlike 
the drug-treated infections, parasite densities were consistently at a detectable level. 
Prior to analysis, estimates of total asexuals and total gametocytes were logio 
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transformed, and proportions of gametocytes were square-root arcs in-transformed, to 
bring the distributions close to normal. The effect of each method of chemotherapy 
relative to the appropriate control infections (i.e. separate analyses were carried out for 
quinine-treated, pyrimethamine-treated, mefloquine-treated, pyrimethamine 
prophylaxis and chioroquine prophylaxis infections) on each of these measures was 
determined by ANOVA using GUM 4 (Crawley 1993), with TREATMENT (drug+, 
drug-) and EXPERIMENTAL BLOCK (each method of chemotherapy was compared 
with untreated infections 2-3 times; see table 4.1) fitted as factors. The interaction 
term was removed from the statistical model if non-significant (p > 0.05) (Crawley 
1993). Analyses of days of peak gametocyte density for each infection were carried 
out as above, except the data for all drug treatment experiments was pooled together, 
and likewise for all the prophylaxis data. 
Daily rates of gametocytogenesis (g, in equation 3) were highly over-dispersed and in 
no way approximated a normal distribution, regardless of transformation. The data 
consisted of many zeros and very low values, as well as much higher values (figure 
4.2). Even the use of non-parametric ranking procedures is unlikely to provide an 
appropriate solution to this problem, given that variation in the very low values will 
often represent the presence or absence of a single gametocyte in the surveyed 
microscopic fields. A nominal classification system was therefore used, with each rate 
of gametocytogenesis classified as high or low, based on whether the value was less 
or greater than the median of the data set. (The drug treatment and prophylaxis data 
sets were analysed separately). To control for multiple sampling from the same 
infection, the median of a data set was calculated as the median of the medians for each 
infection within the data set. Data for each day was analysed using chi-squared tests 
of independence (with Yates's correction for continuity), to determine whether the 
proportion of infections that had high rates of gametocytogenesis (median > 0.008 and 
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Quinine, pyrimethamine and mefloquine treatment reduced total asexuals by 
approximately 75 % in all cases (table 4.2). Quinine treatment reduced total 
gametocytes by approximately 25 %; the other methods of drug treatment did not result 
in a significant decrease (table 4.2). The proportion of parasites that were gametocytes 
was approximately 4 times higher following quinine and pyrimethamine treatment, 
than they were in untreated infections; there was no significant difference between 
mefloquine-treated and untreated infections (figures 4.3 & 4.4, table 4.2). 
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Method of 	Total 	 Total 	 Proportion 
chemotherapy asexuals gametocytes 	gametocytes 
(x10 8 ) 	 ( x10 6 ) 	 ( x10 3 ) 
F1,23 = 51. 2** 17 123 	6.17* F 1123 = 5. 18* 
F223 = 2.48 F223 = 1.10 F223 = 2.92 
F221 = 0.36 F221 = 0.29 F221 = 1.06 
25.6 (1.7) 12.8 (1.52) 6.1 (0.9) 
5.36 (1.10) 8.75 (3.20) 29 (16) 
F 115  = 23.8** F 115 = 2.07 F 115  = 16.2** 
F 115 = 3.05 F 115 = 1.51 171,15 = 8.4** 
F 114 = 1.24 F 114 =0.2 F 114 =3.8 
23.71 (1.32) 10 .87 (1.4) 5. 	(0.8) 




Treat. x exp. 
mean (s.e.) drug-




Treat. x exp. 
mean (s.e.) drug-




Treat. x exp. 
mean (s.e.) drug-




Treat. x exp. 
mean (s.e.) drug-
mean (s.e.) drug+ 
cq proph. 
F112  = 26.3** 
17 112 = 1.67 
17 111 = 1.41 
24.51 (1.11) 
5.96 (1.75) 
17 116  = 22.7** 
17 116  = 8.46* 
17 116  = 6.24* 
40.9 (2.1) 
23.4 (4.5) 
F112 = 2.2 
F112 = 554* 
F 111 = 0.95 
12.92 (1.61) 
12.94 (6.76) 
17 116 = 0.76 
F 116  = 23.0** 
17 116  = 5.82* 
13.1 (2) 
12(3.7) 
F 112 = 2.67 
17 112  = 9.38** 
F 111 = 1.16 
6.4 (1.3) 
14(4.7) 
17 117  = 5.67* 
F 117  = 12.14** 





F 123 = 0.15 
F223 = 5.23 
F221 = 0.57 
2.g (0.5) 
3.2 (0.4) 
Treatment 17 121  = 61.74** 17 123 = 3.93 
Experiment F221  = 5.46* F223 = 6.01 
Treat. x exp. F221  = 6.72* F221 = 1.23 
mean (s.e.) drug- 37.2 (3.5) 10.9 (2.3) 
mean (s.e.) drug+ 19.55 (2) 7.35 (1.5) 
Table 4.2: Results of the analyses of total asexuals, gametocytes and the proportion 
of gametocytes. All methods of chemotherapy were analysed against the appropriate 
untreated infections. qu = quinine, py = pyrimethamine, ml = mefloquine, cq = 
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Figure 4.3: Mean + 1 s.e asexual densities (a) & gametocyte densities (b) through 
time for drug-treated and control infections. Data are pooled across experiments. 
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Figure 4.4: Mean + 1 s.e total asexual parasites (a), total gametocytes (b) & 
proportion of gametocytes for all drug-treated and appropriate control infections. 
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There was an approximately 50% reduction in total asexuals, but no significant 
reduction in total gametocytes following both pyrimethamine and chioroquine 
prophylaxis, relative to untreated infections (table 4.2). The resultant proportion of 
parasites that were gametocytes was not significantly different from untreated 
infections following chloroquine prophylaxis, but was almost twice that of untreated 
infections following pyrimethamine prophylaxis (figures 4.5 & 4.6, table 4.2). 
Both clones CR and ER were used in at least one experimental block each for all 
comparisons between individual methods of chemotherapy and the appropriate 
untreated infections. Significant differences between experimental blocks (p  <0.05) 
occurred for total gametocytes and the proportion of gametocytes in the mefloquine 
treatment experiments and for total asexuals, total gametocytes and the proportion of 
gametocytes for both prophylaxis experiments. In all cases, these effects could be 
attributed to significantly higher values in clone CR than clone ER. There were no 
other significant differences between experimental blocks for either of these measures. 
The magnitude of the difference between untreated and prophylaxis infections differed 
significantly between experimental blocks (experimental block by treatment 
interactions) for total asexuals and total gametocytes in the pyrimethamine prophylaxis 
experiments, and for total asexuals in the chioroquine prophylaxis experiments, 
although the treatment effects were always in the same direction within-experimental 
block. These effects can be attributed to different drug doses being used in the 
different experimental blocks. There were no other significant experimental block by 
treatment interactions. 
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Figure 4.5: Mean + 1 s.e. asexual densities (a) & gametocyte densities (b) through 
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Figure 4.6: Mean + 1 s.e total asexual parasites (a), total gametocytes (b) & 
proportion of gametocytes for all prophylaxis and appropriate control infections. 
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Timing of peak gametocyte densities 
Drug treatment resulted in peak gametocyte density on average occurring 3 days earlier 
than in untreated infections (day 11 p.i. and day 14 p.i, respectively; figure 4.3, F 145 
= 9.0, p  <0.01). Prophylaxis did not induce a change in the timing of peak 
gametocyte densities, (peaks in untreated and prophylaxis infections occurring on 
average between days 13 and 14 p.i.; figure 4.5, F 136 = 0.06, p > 0.1). There were 
no significant experimental block or interaction effects (p > 0.1 in all cases). 
Estimates of daily rates of gametocyto genesis 
The results of the analyses of conversion rates through time for drug treatment and 
prophylaxis experiments are shown in table 4.3. Rates of gametocytogenesis 
increased through time, with most conversion rates below the overall median early in 
the infection, and most above the median towards the end (figures 4.7 & 4.8). This 
pattern differed quite markedly for drug-treated infections: almost 50 % of infections 
had rates of gametocytogenesis above the median immediately following drug 
treatment (on day 5 p.i.) and 80 % had rates above the median (compared with 40 % in 
untreated infections) on day 10 p.i. (figure 4.7). In general, the different methods of 
drug treatment resulted in similar patterns of gametocytogenesis through time, except 
on day 5 p.i. when, unlike quinine- and pyrimethamine-treated infections, no 
mefloquine-treated infections had high rates of gametocytogenesis (figure 4.7). 
Patterns of gametocytogenesis through time were similar for prophylaxis and untreated 
infections. The only exception was on day 10 p.i., when the percentage of infections 
with rates of gametocytogenesis above the median were 60 % and 20 % for untreated 
and prophylaxis infections, respectively (figure 4.8). Patterns of gametocytogenesis 
based on the proportion of infections that had high rates of gametocytogenesis were 
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Figure 4.7: Proportion of infections in drug treatment experiments with 
'high' (greater than the median) rates of gametocytogenesis through time. 
Day p.i. 	drug-treated Vs untreated prophylaxis Vs untreated 
5 x21 = 10.2** X 21 = 0.91 
8 X 21 = 0.98 X 2 1 = 0.27 
10 X 
2 1 = 435* X 
2 1 = 3.96* 
12 X 21 = 2.01 X 21 = 1.31 
14 X 21 = 0.033 
16 	 X2- 0 
Table 4.4: Results of analyses of the proportions of infections with 'high' (greater 
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Figure 4.8: Proportion of infections in drug prophylaxis experiments with 'high' 
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Figure 4.9: Mean ± 1 s.e. rates of gametocytogenesis through time for pooled drug-
treatment, prophylaxis & untreated infections. 
4.5 DISCUSSION 
All methods of chemotherapy (i.e. different drugs, used as treatment or prophylaxis) 
reduced the overall numbers of asexual parasites produced during infections, although 
there was not a notable reduction in gametocytes following pyrimethamine and 
mefloquine treatment and both methods of prophylaxis. Quinine treatment did result in 
a small decrease in total gametocytes (approximately 25 %, relative to untreated 
infections), although the proportion of gametocytes to asexuals was approximately 
four times greater than in untreated infections. These results suggest that all methods 
of chemotherapy resulted in an overall increase in gametocytogenesis: more 
gametocytes are produced from a given number of asexuals. These increases in 
gametocytogenesis were apparent in two clones of P. chabaudi, with slightly different 
asexual and gametocyte dynamics. 
Could these large decreases in asexual parasites and no (or disproportionately small) 
decreases in gametocytes be explained by increased mortality of asexual parasites 
relative to gametocytes following chemotherapy? All the antimalarial drugs used are 
more damaging to asexual parasites than mature gametocytes (Desjardins et al. 1988), 
but this is unlikely to explain the results. Although detailed pharmacokinetic data in 
mice of all the drugs are not available, the effective half-life of mefloquine in mice is 
estimated to be 18 hours (Desjardins & Trenholme 1984), and extrapolation from 
human data suggests that this is likely to be the longest half-life of the drugs used 
(Peters 1987). For all the drugs, preliminary studies showed that concentrations 25 % 
of those actually used had no noticeable effect on asexual growth. Changes in the 
relative death rates of gametocytes and asexuals through drug use is therefore only of 
any potential importance during the first 2 days following drug administration, a 
period excluded from the calculation of total numbers of parasites (assuming a 
maximum half-life of 18 hours, after 36 hours maximum drug concentration, = 
original concentration x 0.52).  It seems unlikely that there are other sources of 
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differential mortality that may affect our interpretations. Differences in the relative 
mortality rates of gametocytes and asexuals resulting from differences in immune 
responses between drug-treated and untreated groups requires an as yet unknown 
gametocyte-specific clearance mechanism (Taylor & Read 1997), which is suppressed 
by all the antimalarial drugs used. 
Temporal variation in gametocyto genesis 
In untreated infections, gametocytogenesis occurred at a low rate during the start of 
infections (until day 8 p.i.), and then rapidly increased to a plateau by day 12 p.i 
(figures 4.7 - 4.9). The temporal variation in gametocytogenesis in prophylaxis 
infections was almost identical to that of untreated infections. A noteable difference 
was a delay in reaching high rates of gametocytogenesis, as shown by the greater 
proportion of infections with high rates of gametocytogenesis in untreated infections 
on day 10 p.i. (figures 4.8 & 4.9). In contrast, drug treatment resulted in greater 
alterations in patterns of gametocytogenesis. There was a massive increase in 
gametocytogenesis immediately following drug treatment (day 5 p.i.). Such a rapid 
response to stressful conditions is consistent with studies on P. falciparum in vitro 
(Carter & Miller 1979, Brockelman 1982, Bruce et al. 1990). Drug-treated infections 
also showed greater rates of gametocytogenesis than untreated infections on day 10 
p.i. This was largely responsible for the earlier peak gametocyte densities following 
drug treatment, relative to untreated infections. 
An important finding of this study is the immediate increase in gametocytogenesis 
following drug treatment (on day 5 p.i.). The drugs were clearly at sufficient 
concentrations to kill parasites (figure 4.3). Would drug-imposed increased mortality 
of asexual parasites relative to gametocytes then affect the estimates of day 5 p.i. 
conversion rate in drug-treated infections? The calculation of gametocytogenesis 
makes the assumption that gametocytes between 24 and 48 hours (when they reach 
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maturity) have zero mortality, but that mortality before this is the same as for asexual 
parasites. These assumptions are probably not greatly violated by drug-imposed 
mortality. Specific data for P. chabaudi is not available, although all the drugs used 
are inactive against mature P. falciparum gametocytes but kill immature forms 
(Desjardins et al. 1988). Moreover, mortality during the first 24 hours includes the 
approximately 7 hours it takes for asexual parasites to mature. Given the rapid 
absorption and subsequent parasite-killing activity of these drugs (at least in people; 
Desjardins et al. 1988), drug-induced mortality is likely to be greatest for these pre-
schizont asexual parasites, probably over-shadowing any possible differences in 
mortality of the gametocyte or asexual progeny produced by the survivors of the drug 
treatment. The possibility that gametocytes that reached maturity on day 6 p.i. (which 
might not have been affected by the drug treatment on day 5 p.i.) would result in a 
significant over-estimation of drug-induced gametocytogenesis is also unlikely. The 
half-life of P. chabaudi gametocytes is less than 12 hours (A. Buckling, unpublished 
data), thus very few of the small number of mature gametocytes present on day 6 p.i. 
would contribute to the population on day 7 p.i. 
Broadly speaking, rates of gametocytogenesis increased when parasite multiplication 
rate was low. In all treatments, gametocytogenesis increased towards the end of the 
infection, when parasites were being effectively controlled by the immune system. 
This pattern is consistent with P. falciparum data: parasites from longer established 
infections of Gambian children (as determined by the presence of mature gametocytes) 
had rates of gametocytogenesis six times higher than parasites from younger infections 
(Smalley et al. 1981). Drug treatment (which greatly inhibited parasite replication) 
resulted in an immediate increase in gametocytogenesis, and these infections 
subsequently had high rates of gametocytogenesis sooner than in untreated infections 
(figures 4.3, 4.7 & 4.9). The delay, relative to untreated infections, in reaching high 
levels of gametocytogenesis following prophylaxis seems counter-intuitive, given that 
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prophylaxis also inhibited asexual growth (figures 4.8 & 4.9). However, parasites in 
untreated infections started to decrease in number and showed increased rates of 
gametocytogenesis sooner than in prophylaxis infections (figure 4.5). 
Temporal patterns of gametocytogenesis were largely independent of the drug used, 
although the method of therapy - whether treatment or prophylaxis - had a major 
effect. It is notable however that the immediate increase in gametocytogenesis 
following drug treatment did not occur in mefloquine-treated infections. It is possible 
that for some reason the parasites do not respond to mefloquine-imposed stress. 
Alternatively, the effect occurred but was not detected because gametocyte densities in 
mefloquine-treated infections were generally below the detection threshold on day 7 
p.i. Mefloquine is much faster acting than quinine and especially pyrimethamine 
(Desjardins et al. 1988) and there will therefore have been fewer parasites surviving on 
day 5 p.i. to produce gametocytes observed on day 7 p.i. Treatment with chloroquine, 
a similarly fast acting drug, resulted in almost identical gametocyte dynamics as with 
mefloquine treatment (Buckling et al. 1997, chapter 2). More generally, daily rates of 
gametocytogenesis will have been under-estimated if mortality of asexual parasites is 
greater during the first 24 hours than the second. This was likely the case immediately 
following treatment with all the antimalarial drugs used. 
Field implications 
P. chabaudi infections in mice have qualitatively similar dynamics to P. falciparum 
infections in humans, with peak gametocyte densities occurring after peak asexual 
densities (Carter & Graves 1988). In addition, the reported changes in 
gametocytogenesis in these experiments are consistent with patterns of 
gametocytogenesis in P. falciparum in vitro: gametocytogenesis increases when 
asexual growth is inhibited in general (Carter & Miller 1979, Brockelman 1982, Carter 
& Graves 1988, Bruce et al. 1990, Sinden et al. 1996), or specifically by antimalarial 
drugs (chapter 6). Our results may therefore have implications for antimalarial drug 
use against P. falciparum in the field. First, the reduction in transmission bought 
about by sub-lethal chemotherapy may be much less than expected because of 
compensatory increases in gametocyte production. Second, chemotherapy may result 
in high rates of gametocytogenesis occurring earlier than in untreated infections, 
resulting in earlier high infectivity. Such a phenotype will potentially increase 
transmission under conditions where the speed of transmission is a major component 
in parasite fitness (e.g. during epidemics). The use of gametocyte-sterilising drugs, 
such as primaquine, following periods of high gametocytogenesis (whether induced 
by chemotherapy or by natural host factors as the primary parasitaemia is controlled) 
might have a significant effect on reducing malaria transmission. 
Partially effective vaccines may also stress parasites, at least in the short term. If so, 
they too may generate compensatory gametocyte production similar to that observed in 
this study. In vitro, P. falciparum gametocyte production increased following the 
addition of serum and lymphocytes from P. falciparum infected children (Smalley & 
Brown 198 1) and anti-P. falciparum antibody (Ono et al. 1986). More generally, 
facultative changes in parasite life histories may render medical and veterinary 
intervention less effective than anticipated. 
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Chapter 5 
THE EFFECT OF HOST IMMUNITY ON THE 
TRANSMISSION OF MALARIA PARASITES 
5.1 SUMMARY 
I investigated how partial immunisation against the rodent malaria parasite, 
Plasmodium chabaudi, affected the transmission of the parasite from subsequent 
infections. Immunisation resulted in similar reductions in both asexual parasite and 
gametocyte (the stage infective to the mosquito vector) densities, although there were 
compensatory increases in gametocyte production during the early parts of the 
infection. There was also strong evidence of strain (genotype)-specific immunity: 
asexual densities were lower following immunisation with an identical clone as the 
challenge infection (homologous challenge), compared with when the immunising and 
challenge clones were different (heterologous challenge). The infectivity of 
gametocytes, as measured by the proportions of mosquitoes infected, was 
approximately five times greater in controls and heterologous challenges than 
homologous challenges. This suggests the occurrence of strain-specific gametocyte 
infectivity-reducing immunity. The results are discussed in the context of 
epidemiology and evolution. 
5.2 INTRODUCTION 
In areas with high rates of malarial transmission, individuals generally develop clinical 
immunity to malaria by about five years of age (Greenwood 1997). However, in 
younger children and in areas where malaria is less endemic, immunity to malaria is 
frequently only partially protective (McGregor & Wilson 1988). Similarly, partial 
protection against malaria is all that can be realistically expected of vaccines that may 
be in use in the near future (Greenwood 1997). It is therefore of great interest to know 
how partial host immunity against malaria might affect the transmission of the disease. 
Malarial infections are maintained by continual cycles of invasion of red blood cells, 
asexual replication and release of the progeny. A small proportion of parasites, which 
can be modulated by environmental conditions (Carter & Graves 1988), develop into 
non-replicating transmission stages (gametocytes). These are the only stages capable 
of infecting the mosquito vector. The number of gametocytes produced during the 
course of an infection is a good measure of parasite transmission success: both the 
probability of mosquito infection and the parasite burden per mosquito increase with 
gametocyte density (Carter & Graves 1988, Taylor & Read 1997, Taylor et al. 1997, 
chapter 3). 
Incomplete immunity to malaria, both in humans and laboratory models, generally 
results in a reduction in the total numbers of asexual parasites that are present during 
the course of an entire infection, by reducing asexual densities and / or infection 
longevity (Graves et al. 1988, Jarra & Brown 1985, Jarra et al. 1986, Bates et al. 
1988). This is likely to result in a reduction in the total number of gametocytes 
produced during the infection for two reasons. First, there will be fewer asexuals to 
produce gametocytes. Second, there is likely to be some cross-immunity between 
asexuals and gametocytes (Motard et al. 1995, Goodier & Targett 1997). Partial 
immunity can further reduce Plasmodium transmission success, by 'sterilising' 
gametocytes and / or the resultant gametes in the mosquito midgut ('transmission-
blocking' immunity; Mendis et al. 1987, Graves et al. 1988, Graves et al. 1991, 
Mulder et al. 1994, Sinden 1997). 
Studies using the rodent malaria parasites P. chabaudi and P. berghei have shown that 
partial anti-parasite immunity is in part strain (genotype)-specific. Both peak asexual 
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densities and the duration of the patent infection are less for animals challenged with 
the same genotype as used for immunisation (homologous challenge), compared with 
animals challenged with a genotype different from the immunising genotype 
(heterologous challenge) (McLean et al. 1982, Jarra & Brown 1985, Jarra et al. 1986, 
Bates et al. 1988). Strain-specific immunity has also been experimentally 
demonstrated for the human malaria parasites P. falciparum and P. vivax (Boyd 1942, 
Jeffery 1966, Sadun etal. 1966, Cadigan & Chaicumpa 1969). Whether strain-
specific transmission-blocking immunity also occurs is unkown. 
Host immune status may also influence the proportion of asexual parasites that 
produce gametocytes. Increased gametocytogenesis has been reported in response to 
conditions that do not favour asexual multiplication, including high parasite densities 
(Brockelman 1982, Bruce etal. 1990) and antimalarial chemotherapy (Buckling etal. 
1997, chapters 2, 4 & 6). Assuming poor asexual growth in vivo to be a good 
indicator that the infection will soon be cleared, an increase in gametocyte production 
in response to stress would increase the overall transmission success of the parasite, 
and thus be favoured by natural selection (Stearns 1992, Roff 1992, Buckling et al. 
1997, chapter 2). Partial immunity against malaria parasites reduces asexual growth 
and infection longevity. Increased gametocyte production of the rodent malaria, P. 
yoelii, in vivo has been reported following immunisation with a recombinant malarial 
heat shock-like protein that is expressed throughout the life cycle (Motard etal. 1995), 
and in P. falciparum (the most common and virulent human malaria) after the addition 
of immune serum and lymphocytes (Smalley and Brown 198 1) and anti-P. falciparum 
antibody (Ono et al. 1986). 
I carried out experiments with the rodent malaria P. chabaudi to address the following 
questions. First, does partial immunity reduce transmission? Second, does strain-
specific immunity acting against asexual parasites result in strain-specific transmission 
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success? Third, does immunisation change gametocyte infectivity, and if so does it do 
so in a strain-specific manner? Finally, does immunisation change patterns of 
gametocytogenesis, and if so does it do so in a strain-specific manner? 
5.3 MATERIALS AND METHODS 
Immunisation and infection 
Male C57/BL/6J mice (Harlan-Olac, England) aged 8-14 weeks were immunised with 
lx 104 red blood cells (RBCs) infected with a P. chabaudi clone (either CR or ER, 
from the WHO Registry of Standard Malaria Parasites maintained at the University of 
Edinburgh, UK) in a 0.1 ml intra-peritoneal inoculum of 50 % ringer's solution (27 
mM KC1, 27 mM CaCl2, 0.15 M NaCl), 45 % heat-inactivated calf serum and 5 % 
200 units I ml heparin solution. ER and CR probably differ at a number of loci, and 
are known to differ at the immunogenic surface antigen MSP1 (McLean et al. 1991). 
Control (non-immunised) animals were inoculated with uninfected RBCs in the same 
volume of inoculum solution. Four days post-infection (p.i.), all mice were treated 
orally, using a lubricated catheter, with 25 mg I kg mefloquine solution, prepared by 
dissolving mefloquine sulphate in 60 °C distilled water with a magnetic stirrer. 
Treatment was repeated over the next 2 days, to ensure infection clearance, which was 
confirmed by extensive examination (<500 microscopic fields) of Giemsa-stained 
weekly blood-smears (see below), until reinfection. Four weeks after the first day of 
drug treatment, mice were infected with lx 106  parasites of either clone CR or ER. The 
length of the immunising infection and the amount of time before challenge were 
determined from preliminary experiments to result in partial protection against the 
subsequent challenge. Mice infected with each clone could be classified into 3 
treatment groups: non-immune (naive), homologous challenge and heterologous 
challenge. Mice, age-matched within experiments, were housed in cages of 3-5 
animals at a temperature of 25±1 °C with a 0700 to 1900 hours light cycle, and 
provided with 41B rat and mouse maintenance diet (Harlan-Teklad, England) and 
water containing 0.05 % pABA, ad libitum. Details of the sample sizes used in the 
two replicate experiments and the experimental design can be found in table 5.1. 
Immunising 	Challenge 	Sample size: 
clone 	 clone 	 Expt 1 	Expt 2 
CR CR 3 5 
ER CR 3 3 
none CR 4 3 
ER ER 3 5 
CR ER 3 4 
none ER 3 5 
Table 5.1: Details of experiments. Expt, Experiment. Sample size refers to number 
of animals within each treatment. 
Parasite counts 
Every second day, between days 5 and 17 p.i. and 1700 - 1800 hours, thin blood 
smears from the tail vein were Giemsa stained and asexual parasites counted per 1.5 x 
103 RBCs. At low asexual densities parasites were counted per 1.25 x 104  RBCs. 
Mature gametocytes were counted per 1.25 x 104 RBCs. Parasite densities were 
calculated from the product of RBC densities (measured every second day using flow 
cytometry; Coulter ElectronicsTh1)  and parasites I RBC. 
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Mosquito feeds & dissections 
On day 7 p.i. (when preliminary experiments revealed the presence of gametocytes in 
the majority of mice) in each experiment, 2 mice per treatment group per clone were 
assayed for infectivity by allowing Anopheles stephensi mosquitoes to feed on them. 
Mice were anaesthetised by an intra-muscular injection of 0.5 ml per 20 g mice 3:2:1 
distilled water: Vetal arTM : RompunTM, and placed onto pots covered with nylon mesh 
containing -40 4-5 day old female A. stephensi, which had been starved for the 
previous 24 hours. Mosquitoes were left to feed in the dark for 30 minutes, between 
1845 and 1945 hours. After removal of unfed mosquitoes, the remainder were 
maintained at 25-30 °C, 70-80 % humidity, with a 12 hour light cycle and provided 
with 5 % glucose, 0.05 % pABA solution ad libitum. After 8-9 days, approximately 
25 mosquitoes per mouse were dissected to determine the presence of oocysts on 
midguts. 
Statistical analyses 
Comparisons of naive and immunised hosts were made by analyses of the following 
summary measures for each infection. A number of mice in each experiment died 
(from severe anaemia) between days 8 and 12 p.i. These were excluded from all 
analyses except infectivity to mosquitoes, which was assayed only on day 7 p.i. 
(1) Total asexuals. This was estimated from parasite densities between days 5-17 p.i. 
by integrating under the parasite density through time curves for each infection. This 
is a reasonably accurate measure of total numbers of asexuals (between days 5-17 p.i.) 
because the asexual cycle of P. chabaudi is known to be 24 hours (Cox 1988). Before 
day 5 p.i. and after day 17 p.i., parasites densities are negligible relative to the total 
produced in the intervening period. 
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Total gametocytes. This was estimated for the same time period as for total 
asexuals (days 5-17 p.i.), during which the bulk of gametocyte production occurs. 
This measure is a reasonable estimate of total gametocyte numbers because the half life 
of a mature gametocyte is estimated to be less than 12 hours (A. Buckling, 
unpublished data). In addition, the sum of the gametocyte densities on each day is 
likely to be a well correlated with total transmission probability: gametocyte densities at 
any point in time correlate with both the proportion of mosquitoes infected and 
densities within mosquitoes (Taylor & Read 1997). 
Proportion of gametocytes. This was calculated as the proportion of total 
parasites [(l)+ (2)1 that were gametocytes [2] for each infection. 
The proportion of mosquitoes infected 
Daily rates of gametocyto genesis 
We used a simple exponential growth model to estimate the proportion of asexual 
parasites that produced gametocytes on individual days. Rates of gametocytogenesis 
(g) on day t were calculated for days (t =) 5, 7, 9, 11 and 13 p.i. using 
- 
- 	 (1), g 
A 
A 4 
where A and G refer to asexual and gametocyte densities, respectively, on a given day. 
Equation 1 takes into account differential mortality between asexual parasites and 
gametocytes, and differences in their maturation periods and longevity. Details of the 
model can be found in section 4.3. 
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Prior to analysis, estimates of total asexuals and total gametocytes were log 10 - 
transformed and proportion of gametocytes square-root arcsin-transformed, to bring 
their distributions close to normal. All analyses were carried out using generalised 
linear models (GLIM; Crawley 1993). Starting with the highest order interactions, all 
factors, covariates and their interactions were individually removed in turn from the 
complete model. Non-significant interaction terms were removed and test statistics 
obtained from the resulting minimal model. 
The effect of immunisation per se on (1) total asexuals, (2) total gametocytes and (3) 
the proportion of gametocytes was determined by ANOVA, with TREATMENT 
(immunised or naive), CLONE (ER or CR) and EXPERIMENT (1 or 2) fitted as 
factors. The effect of strain-specific immunity on these measures was determined by 
carrying out separate analyses using only immunised animals, with IMMUNISING 
CLONE (ER or CR), CHALLENGE CLONE (ER or CR) and EXPERIMENT fitted 
as factors. Detection of a significant interaction between the immunising clone and the 
challenge clone is evidence that strain-specific immunity has occurred (Read & Viney 
1996). 
A binomial error structure was used for the logistic regression of probability of a 
mosquito becoming infected (Crawley 1993). Square-root arcsin-transformed 
gametocytaemia on the day of the feed (gametocytes / RBC; the best correlate of 
infection probability on an individual day, chapter 3) was fitted as a covariate. The 
data did not require correction for over-dispersion. 
Daily rates of gametocytogenesis (g, in equation 1) were highly over-dispersed and in 
no way approximated a normal distribution, regardless of transformation. The data 
consisted of many zeros and very low values, as well as much higher values. Even 
the use of non-parametric ranking procedures is unlikely to provide an appropriate 
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solution to this problem, given that variation in the very low values will often represent 
the presence or absence of a single gametocyte in the surveyed microscopic fields. A 
nominal classification system was therefore used, with each rate of gametocytogenesis 
classified as high or low, based on whether the value was less or greater than the 
median of the entire data set. To control for multiple sampling from the same 
infection, the median of a data set was calculated as the median of the medians for each 
infection within the entire data set. Data for each day was analysed using chi-squared 
tests of independence (with Yates's correction for continuity), to determine whether 
the proportion of infections that had high rates of gametocytogenesis (median> 
0.0006) differed between immunised and naive animals. 
5.4 RESULTS 
Infection dynamics 
Immunisation resulted in a three-fold reduction in the mean numbers of total asexual 
parasites (figures 5. la, 5.2a & 5.3a, table 5.2), and a four-fold reduction in total 
gametocytes (figures 5. ib, 5.2b & 5.3b, table 5.2). The resultant proportion of 
gametocytes did not significantly differ between immunised and naive animals (figure 
5.3c, table 5.2). There was no difference between the two clones in either total 
asexuals (figure 5.3a,table 5.2) or gametocytes (figure 5.3b, table 5.2), although the 
ratio of gametocytes to asexuals in clone CR was approximately twice that of clone ER 
(figure 5.3c, table 5.2). 
Animals challenged with the same clone that they were immunised with (homologous 
challenge) had fewer total asexual parasites than animals challenged with the other 
clone (heterologous challenge) (figure 5.3a, table 5.3). In other words, asexual 
parasites were noticeably affected by strain-specific immunity. There was no evidence 
that strain-specific immunity affected either total gametocytes (figure 5.3b, table 5.3) 





















immunity, whether clone ER or CR were used as the immunising or challenge clone 
had no effect on total asexuals, total gametocytes or the ratio of the two (figure 5.3, 
table 5.3). In other words, the clones did not appear to differ in their immunogenecity 
or how much they were affected by immunisation. 
Total 	 Total 	 Proportion 
Asexuals 	Gametocytes 	Gametocytes 
Treatment 	 F140 = 58.8** 	i 	= I 8** 	F 140 = 1.7 '1,40 	' 
Clone 	 F 140  :- 0.01 F 140 = 1.84 F 	= 8.9** 1,40 ' 
Experiment 	 =4.8* 	F = 5 .7* 	F 140 = 1.4 '1,40 1,40 	' 
i awe 	esuits or anaiyses or tne errect or immunisation treatment on various 
summary measures. All interaction terms were removed from the model, as they were 
non-significant (p  >0.1). * p <0.05; ** p <0.01. 
Figure 5.1: Dynamics of infections with clone CR. Mean (+1 s.e.) asexual 
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Figure 5.2: Dynamics of infections with clone ER. Mean (+1 s.e.) z°xual 
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Figure 5.3: Estimates of (a) total asexual parasites, (b) total gametocytes and (c) the 
proportion of gametocytes, between days 5 - 17 p.i. for all treatments. Plotted points 
are means ± 1 s.e. 
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Total Total Proportion 
Asexuals Gametocytes Gametocytes 
1mm. clone 	F 123 = 0.68 F 124 = 0.35 F 124 = 2 
Chall. clone F 123 = 0.67 F124 = 0.8 F 124 = 3.4 
1mm. x chal. 	F123  = 10.6* F 123 = 1.42 F 124 = 0.27 
Experiment F 123  = 8.5* F124 = 3.6 F124 = 0.06 
Table 5.3: Results of analyses of infections in immunised animals only. the effect of 
dimmunisation (treatment) on various summary measures. All other interaction terms 
were removed from the model, as they were non-significant (p >0.1). * p < 0.01. 
Rates of gametocytogenesis in control animals were at a low level up until day 11 p.i., 
when they rapidly increased. There was a similar pattern in immunised animals, 
although rates of gametocytogenesis were generally higher than in control animals 
before day 11 p.i. - noteably so on day 7 p.i. (figure 5.4, X21 = 5.4, p = 0.02). There 
were no other significant differences in rates of gametocytogenesis between control 
and immunised animals on the other days (figure 5.4, p  >0.1 in all cases). 
Infectivity 
The proportion of mosquitoes infected increased with gametocytaemia at the time of 
the feed (figure 5.5, table 5.4), and at the same rate for both clones and all three types 
or treatment (table 5.4). The relationship between the proportion of mosquitoes 
infected and gametocytaemia was linear: the addition of the quadratic term to the 
untransformed data did not explain a significant amount of deviance (p > 0.1). After 
gametocytaemia had been controlled for, infectivity per gametocyte was reduced five-
fold (at the mean gametocytaemia) in homologous challenges, compared to that in 
heterologous challenges and controls (figure 5, table 5.4), which did not differ (figure 
5.5, table 5.4). Gametocyte infectivity was between 2 - 3 times higher for clone ER 
than CR (table 5.4). 
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Figure 5.4: Proportion of control and immunised infections (challenged with clone 
CR or ER) with 'high' (greater than the median) rates of gametocytogenesis through 
time. See text for details. 




Experiment 9.1 * 
Table 5.4: Minimal model of logistic regression of mosquito infection probability. 
Treatment was simplified to a 2 level factor: (control + heterologous challenge) and 
homologous challenge with a non-significant increase in deviance (x21 = 0.73). No 
interactions were significant (p>0.1). *p  <0.01; **p , 0.001. 
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Figure 5.5: The relationship between the proportion of mosquitoes infected and 
gametocytaemia on day 7 p.i. Lines are ordinary least squares regression lines. 
Numbers within the graph show multiple data points. 
5.5 DISCUSSION 
Immunisation against P. chabaudi resulted in reductions in both peak asexual densities 
and infection longevity, and as a result, the total number of asexual parasites during 
the infection. Consistent with previous studies (McLean et al. 1982, Jarra & Brown 
1985, Jarra et al. 1986, Bates et al. 1988), we found evidence of strain-specific 
immunity: total numbers of asexuals were less in animals that had been challenged 
with the homologous compared with the heterologous clone (figure 5.3a). The 
occurrence of strain-specific asexual immunity is unsurprising given the difference 
between clones ER & CR at a known immunogenic antigen, MSP 1, to which allele-
specific protective antibody responses are well documented (McLean et al 1991). 
There was also a reduction in the total number of gametocytes following 
immunisation, although this did not differ between the two methods of immunisation 
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(5.3b). Based on the within-host data, the low-level immunisation in these 
experiments would reduce parasite transmission success four-fold, independent of 
whether the challenge was homologous or heterologous. 
The infectivity of gametocytes in a heterologous challenge was not reduced. 
However, in homologous challenges, gametocyte infectivity was reduced five-fold 
(figure 5.5). As with strain-specific asexual immunity, the magnitude of this effect 
was independent of whether clone CR or ER were used as the challenge infection. 
Given that total numbers of gametocytes did not differ between the two methods of 
immunisation, gametocyte infectivity is likely to be the major factor in determining the 
overall transmission success of a parasite strain in a partially immune host. 
How could these differences in gametocyte infectivity between homologous and 
heterologous challenges arise? Asexual parasite density has been reported to 
negatively correlate with gametocyte infectivity in the rodent malaria, P. berghei 
(Dearsley et al. 1990, Sinden 1991). This is clearly not the case in this study, as 
asexual densities were higher in heterologous than homologous challenges on the day 
of the mosquito feed (day 7 p.i., figures 5. la & 5.2a). The most likely explanation is 
therefore immunity reducing gametocyte infectivity in a strian-specific manner: 
gametocytes in a host that are of the same genotype as used for immunisation have 
greatly reduced infectivity relative to that in hosts immunised with an alternative 
genotype. Such strain-specific immunity requires polymorphisms in immunogenic 
gametocyte I gamete antigens. This possibility cannot be addressed for P. chabaudi, 
as there is a paucity of relevant data. We therefore consider data from P. falciparum, as 
it is likely that P. chabaudi, like P. berghei, possesses many of the equivalent P. 
falciparum gametocyte I gamete antigens (Sinden 1997). 
Transmission-blocking activity has been reported for antibodies against two P. 
falciparum gametocyte / gamete-specific antigens, Pfs 48 /45 (Carter etal. 1990, 
Targett etal. 1990) & Pfs 230 (Graves etal. 1988). Polymorphisms have been 
reported in Pfs 48 / 45 (Foo etal. 1991, Roeffen et al. 1996), Pfs 230 (Williamson & 
Kaslow 1993), and Pfg 27 / 25 (Alano etal. 1996), another potential transmission-
blocking target antigen (Sinden 1997), suggesting that variation exists for strain-
specific transmission-blocking immunity to operate. The transmission-blocking 
activity of antibody to both these antigens is, however, by no means ubiquitous 
(Roeffen etal. 1996, Healer et al. 1997). In addition, it would be surprising if an 
effective transmission-blocking immune response could by raised against the P. 
chabaudi equivalent of these antigens, given the short duration of the immunising 
infection and the inevitably small numbers of gametocytes that would have been 
present. A more parsimonious explanation is that the strain-specific reduction in 
gametocyte infectivity is a result of strain-specific anti-asexual immunity cross reacting 
with shared (polymorphic) gametocyte antigens. Highly polymorphic and 
immunogenic antigens (encoded by var genes; Roberts etal. 1992) are expressed on 
the surface of asexual-infected RBCs. If also expressed on gametocytes, immunity 
acting against these antigens on asexual parasites could potentially mediate the 
observed reduction in gametocyte infectivity following homologous challenge. If this 
interpretation is correct, the phenonemena is not, by definition, 'transmission-blocking 
immunity', which is mediated by antibody raised specifically against gametocyte / 
gamete antigens. 
Averaged across the whole infection, there was no difference in the proportion of 
parasites that were gametocytes between control and immunised animals. Similarly, 
there was no difference between homologous and heterologous challenges (figure 
5.3c). This implies that neither method of immunisation resulted in compensatory 
increases in gametocyte production. The effect of immunisation differed from that of 
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antimalarial drug treatment and prophylaxis (using doses that did not kill all parasites), 
which resulted in large reductions in asexual parasites but either no, or a 
disproportionately small, reduction in gametocytes (Buckling etal. 1997, chapters 2 
and 4). 
Consideration of the estimates of daily rates of gametocytogenesis suggest that 
gametocytogenesis was however higher in immunised animals. In both immunised 
and control animals, rates of gametocytogenesis increased towards the end of the 
infection (from day 11 p.i., figure 5.4). Before this period, parasites had higher rates 
of gametocytogenesis in immunised than control animals. These data support the 
hypothesis that conditions unfavourable for asexual growth result in increased 
gametocytogenesis: in all treatments asexual growth decreased as the infection 
progressed, and asexual growth for the first nine days of the infection was less in 
immunised than control animals (figure 5.1a & 5.2a). This pattern was the same for 
both clones. 
As daily rates of gametocytogenesis were generally higher in immunised than control 
animals, why was there no difference in gametocytogenesis estimated across the entire 
infection? Rates of gametocytogenesis were at their highest, and did not differ 
between infections in immunised and control animals, between days 11 and 15 p.i. 
(figure 5.4). As a result, the bulk of gametocytes produced during the course of a 
control infection are produced after day 11 p.i., even though the asexual population at 
this time is much less than earlier in the infection (figures 5.1 & 5.2). Asexual 
densities after day 11 p.i. were disproportionately smaller in immunised than control 
animals, relative to before day 11 p.i. There was thus no overall increase in the 
proportion of gametocytes in immunised animals. 
When comparing estimates of gametocytogenesis between immunised and control 
animals, the possibility that relative mortality rates of asexuals and gametocytes may 
differ between the treatments needs to be considered. Indeed, immunity is likely to be 
greater against asexual parasites than gametocytes, given that the immune system 
would have encountered very few gametocytes before the brief immunising infection 
was drug cleared. Two points strongly suggest this possibility would not bias our 
estimates of gametocytogenesis in immunised relative to control animals. First, 
asexual parasites have to survive to produce gametocytes. Second, the half life of a 
mature gametocyte is less than 12 hours (A. Buckling, unpublished data), thus 
surviving gametocytes would contribute little to the gametocyte population when the 
next measure was taken, two days later. 
Implications 
Strain-specific immunity against asexual parasites has been demonstrated for both P. 
falciparum and P. vivax (Boyd 1942, Jeffery 1966, Sadun et al. 1966, Cadigan & 
Chaicumpa 1969). If the data from this study on P. chabaudi are of general relevance, 
the results may have implications for understanding the epidemiology of human 
malaria and the effects of partially protective vaccines. Although partial host immunity 
against malaria may result in compensatory increases in gametocytogenesis, it is likely 
to have a large impact on reducing malaria transmission. These data would suggest a 
reduction between 75 % and 90 % depending on whether the immunising strain / 
antigen was heterologous or homologous to the challenge infection. Further 
reductions would be expected at higher levels of immunity. It is important to note that 
the difference in infectivity between heterologous and homologous immunisation was 
primarily brought about by strain-specific gametocyte infectivity-reducing immunity. 
Strong strain-specific, in addition to strain-independent, immunity is likely to have a 
large effect on the population structure of Plasmodium, by reducing the probability of 
multiple clones being transmitted. The subsequent decrease in the average number of 
clones per host has a number of potentially important implications, including 
reductions in outcrossing rates, further reductions in transmission (Taylor et al. 1997), 
and a decrease in the probability of parasites evolving resistance to multiple 
antimalarial drugs (Mackinnon & Hastings 1997). Partially effective vaccines may 
therefore have a large impact on reducing malaria transmission. This conclusion 
ignores possible long term parasite adaptations to varying levels of host immunity, as 
well as strain-specific immunity allowing different parasite strains to be transmitted 
largely independently of each other, resulting in a reduction in the selection against 
highly virulent genotypes (Gupta et al. 1994a, b, Gupta et al. 1996). 
The occurrence of strong strain-specific immunity will result in a short-term selective 
advantage of Plasmodium strains that have newly invaded a host population. This 
advantage will soon be lost after host immunity has developed against the new strains. 
If intragenic recombination is sufficiently common, or there is some epistasis between 
genes encoding antigens, recombinant progeny are also likely to have a short-term 
selective advantage relative to the parental genotypes. This advantage of the 
continuous production of antigenically novel genotypes may help to explain why 
sexual reproduction is ubiquitous in the life cycle of malaria. Sex as an immune 
evasion mechanism has been previously suggested for a facultatively sexual 
gastrointestinal nematode of rats, Strongyloides rani (Genmiill et al. 1997). 
Chapter 6 
CHLOROQUINE INCREASES PLASMODIUM 
FALCIPARUM GAMETOCYTOGENESIS IN VITRO 
6.1 SUMMARY 
Malaria parasites are capable of modulating the diversion of resources from asexual 
growth to the production of stages infective to mosquitoes (gametocytes). Increased 
rates of gametocytogenesis appear to be a general response to stress, both naturally 
encountered or novel. I have previously reported earlier and greater 
gametocytogenesis in response to sub-curative antimalarial chemotherapy in the rodent 
malaria, Plasmodium chabaudi, in vivo. Using an immunofluorescent assay to detect 
parasites that had invaded red blood cell monolayers, I demonstrate a five-fold increase 
in gametocytogenesis in the human malaria, P. falciparum, in vitro, in response to 
treatment with the antimalarial drug chioroquine. In all clones used, 
gametocytogenesis increased with increasing inhibition of asexual growth by 
chloroquine. Furthermore, there were clone differences in the relationship between 
stress and gametocyte production, implying the response was genetically variable. 
This was not however associated with chloroquine resistance. The epidemiological 
significance of these results are discussed. 
6.2 INTRODUCTION 
Malaria parasites (Plasmodium spp.) are capable of modulating the proportion of 
blood-stage asexual parasites that develop into non-replicating transmission stages 
(gametocytes). Both the probability of mosquito infection and the parasite burden per 
mosquito increase with gametocyte density (Carter & Graves 1988, Taylor & Read 
1997, Taylor et al. 1997, Buckling et at. 1997, chapter 2). Conditions unfavourable 
for asexual growth, and thus future transmission opportunities, result in an increase in 
short-term gametocytogenesis (the proportion of asexual parasites that produce 
gametocytes; Mons 1985, Carter & Graves 1988, Sinden etal. 1996). By showing 
such compensatory increases in gametocytogenesis, malaria parasites are likely to 
increase the total number of hosts infected from the current infection. 
If increased gametocyte production is a general response to stress, it is predicted to 
occur following human-imposed stresses, such as antimalarial chemotherapy. Most 
antimalarial drugs kill asexual parasites. However, if some parasites survive (sub-
curative treatment is common in the field; Wernsdorfer 1994), they will inevitably 
suffer some damage (the extent of which is likely to correlate with the drug-imposed 
mortality), and may be expected to have a higher probability of producing 
gametocytes. 
A number of clinical trials with P. falciparum in people have investigated drug-induced 
gametocytogenesis (reviewed in Buckling etal. 1997, chapter 2). However, for 
ethical reasons, there were no untreated control groups, and drugs were given in 
curative doses. Detection of increased gametocytogenesis is clearly impossible from 
these experiments, and the data are, not surprisingly, very ambiguous. I have 
previously reported increased gametocyte production (and subsequent infectivity to 
Anopheles stephensi mosquitoes) following sub-curative chemotherapy in the rodent 
malaria, P. chabaudi, in vivo (Buckling et al. 1997, chapters 2 and 4). In these 
experiments, a variety of drugs with different parasite-killing mechanisms were used 
against drug-naive parasite clones, suggesting the response is a general adaptation to 
stress, the drugs mimicking naturally encountered stresses, such as host immunity. 
Precise assessment of gametocytogenesis is however difficult in vivo, given the 
possibility of different mortality rates and spatial distributions of asexual parasites and 
gametocytes. In vitro experiments overcome these problems as well as allowing the 
study of the human malaria parasite, P. falciparum. 
I carried out experiments to determine whether the most commonly used antimalarial 
drug, chioroquine, increases gametocytogenesis in P. falciparum in vitro. Antimalarial 
drugs by definition kill asexual parasites, radically changing culture conditions, 
therefore a simple comparison of the parasite dynamics between untreated and 
chloroquine-treated continuous cultures can not adequately test the hypothesis. 
Commitment of parasite progeny to developing either as asexual parasites or 
gametocytes occurs prior to release from the parent schizont (Bruce et al. 1990). We 
were able to isolate the progeny of parasites exposed to short-term control and drug 
treatments by allowing controlled invasion of red blood cell (RBC) monolayers. The 
phenotypes of the progeny were then determined after two days using an 
immunofluorescence assay, rather than potentially ambiguous morphological 
characterisation. Using these techniques we were also able to investigate the precise 
relationship between drug-induced stress and gametocytogenesis and possible 
differences in such responses between chloroquine-sensitive and -resistant parasite 
clones. 
6.3 MATERIALS & METHODS 
Parasite culturing and chioroquine treatment 
Parasites were cultured following a modification of the methods of Trager & Jensen 
(1976). Four P. falciparum clones were used in the study: chloroquine-sensitive 
3137A and HB3B and chloroquine-resistant 7G8 and SUD12418 (all from the WHO 
Register of Standard Strains of Malaria Parasites, maintained at the University of 
Edinburgh). 3D7A is a clone (Walliker et al. 1987) made from isolate NF54 
(Ponnundurai et al. 1981), which was obtained from a patient in the Netherlands. The 
geographical origin is unknown, although there is some suggestion that the parasite is 
from Africa (Collins et al. 1986). HB3B, 7G8 and SUD124/8 was cloned from the 
Honduran isolate Hi (Bhasin & Trager 1984), the Brazilian isolate IMTM22 (Burkot 
et al. 1984), and the Sudanese isolate SUD124 (Bayuomi et al. 1993), respectively. 
M. 
Parasite cultures were prepared at 5 % haematocrit using freshly washed group 0 +, 
group RhD + human RBCs (Edinburgh and South East Scotland Blood Transfusion 
Service) in complete RPMT medium (RPMI 1640 supplemented with 25 mM HEPES, 
80 mg / 1 gentamicin sulphate, 50 mg / 1 hypoxanthine, 0.2 % w/v NaHCO 3 and 10 % 
v/v pooled, heat-inactivated human serum). Cultures were established with an initial 
parasitaemia (parasites / RBC) of approximately 1 % in 5 ml volumes in 25 ml sterile 
polystyrene tissue culture flasks (Corning). Cultures were maintained at 37 'C and 
gassed daily with a mixture of 3 % CO211 % 02  & 96 % N2 . The medium was also 
replaced daily, with fresh pre-warmed medium. 
When a large proportion of the parasites were at the 'late ring' stage (less than 24 
hours old) and the culture parasitaemia was at least 4 %, two identical subcultures with 
parasitaemias ranging between 2 - 4 % were established from the original culture. One 
was treated with chioroquine sulphate (Nivaquine"; see table 6.1 for doses) diluted in 
distilled water, and the other treated with an equal volume of distilled water (10 p1). 
The medium was replaced with untreated medium approximately 17 hours later. 
Parasites were cultured for a further 48 hours, at a volume of 4.5 ml because of 
removal of culture for RBC monolayer invasion (see below). From the day of the 
addition of chioroquine (day 0), daily thin blood smears were taken, Giemsa-stained 
and the number of asexual parasites counted per 1.5 x 10' RBCs. One pair of cultures 
was termed one experiment. Either 6 or 7 experiments were carried out for each clone 
(see table 6.1); experiments were carried out by themselves or two at a time. 
Preparation and infection of RBC monolayers 
The method for creating RBC monolayers was based on that of Jackie Williams 
(Inselburg 1983). Corning polystyrene tissue culture dishes (35 x 10 ml) were 
incubated with 1.5 ml 10 pg / ml Concanavalin A (Sigma). Except when being 
manipulated, culture dishes were kept in a modulator incubator at 37 °C at all times. 
The Concanavalin A was then removed and the dishes washed twice with incomplete 
RPMI medium (RPMI 1640 supplemented with 25 mM HEPES and 50 mg /1 
hypoxanthine). The dishes were incubated for a further 60 minutes with 1.5 ml of 
washed, uninfected RBCs at 0.5 % haematocrit suspended in incomplete RPMI 
medium. Unbound RBCs were carefully resuspended and removed by aspiration, and 
the monolayer was washed twice more with incomplete RPMI medium, to completely 
remove any unbound RBCs. 
Shortly after removal of the chloroquine, 0.5 ml of each culture was removed from the 
culture flasks and diluted in complete RPMI medium to 0.5 % haematocrit and 1.5 ml 
of this culture was added to each monolayer (three monolayers per culture). The 
modular incubator was gassed and the parasites kept at 37 °C for 18-22 hours, to 
allow invasion of the monolayer. Unbound RBCs were resuspended in complete 
medium and removed. The monolayers were washed twice more with complete RPMI 
medium, to remove any unbound cells. This method allows only the progeny of the 
cohort of parasites that had been exposed to the experimental treatments to invade the 
monolayers. Because the progeny in the monolayer were never directly exposed to 
chloroquine, chloroquine-induced differential mortality between gametocytes and 
asexual parasites was controlled for. The culture dishes were gassed and left for a 
further 24 hours. This prevented a further asexual cycle occurring in the monolayer, 
which would have resulted in parasites whose predecessors would not have been 
exposed to the appropriate treatments. The complete RPMI medium was then removed 
and the monolayers left to air dry. After determining whether parasite invasion was 
suitable for the subsequent assay by methanol-fixing and Giemsa-staining one of the 
three monolayers per culture, the remaining dishes were wrapped in foil and stored 
anhydrously at -70 °C until the immunofluorescence assay was carried out. A 








after 17 hours. 





Mature parasite 	Immature parasite 
RBC 1cXXTXTX:TJ Parasites left to invade 
RBC monolayer for 18-22 
hours. Parasites not in 
monolayer removed. 
Parasites mature in 
monolayer for further 
24 hours. 
Figure 6.1: Schematic of methods for basic experimental design (a), and events 
within RBC-monolayers (b). 
Clone CQ concentration (pM) 	n 
3137 0.06 - 0.067 	 6 
HB3 0.06 - 0.07 	 6 
7G8 0.075 - 0.4 	 7 
124/8 0.2 - 0.275 	 7 
Table 6.1: Range of chioroquine (CQ) concentrations used for each clone. n; 
number of experiments carried out per clone. 
Immunofluorescence assay (IFA) 
Monoclonal antibodies (mAbs) used were mAb 93a3a2 (IgGi), which reacts to the 
gametocyte-specific Pfs 16 antigen (Baker et al. 1994), and mAb 12.8.2.1 (IgG2b), 
which reacts to the 16 kDa segment of MSP2 (McBride & Heidrich 1987), an asexual-
specific antigen (Stanley et al. 1985). Both were mouse hybridoma culture 
supernatants. Pfsl6 is expressed approximately 30 hours after parasite invasion of the 
RBC (Bruce etal. 1994). The 16 Wa segment of MSP2 is present on both young 
ring stages and is expressed again in the developing schizont (from about 30 hours 
post-invasion; McBride & Heidrich 1987). mAb 12.8.2.1 also showed limited cross 
reactivity to young gametocytes. 
In all cases, WA of monolayers from paired chloroquine-treated and control cultures 
was carried out at the same time. After methanol-fixing of the monolayers, 1 ml of 
'block' buffer (1 x PBS containing 1 % w/v Fraction V bovine serum albumin 
(sigma), 0.05 % NaAzide) was added to each dish, which were then left in a humidity 
chamber for 20 minutes at room temperature. The buffer was then aspirated off and 
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the dishes incubated for 30 minutes in a humidity chamber at room temperature with 
80 jil of block with 1:50 and 1:300 dilutions of mAb 93a3a2 and mAb 12.8.2.1, 
respectively. Dishes were then washed 6 times with 1 x PBS and incubated for a 
further 20 minutes in a humidity chamber at room temperature with 80 p1 of 1 x PBS 
containing 10 pg / ml DAPI (4,6-diamidino-2-phenylindole; Sigma), 0.05 % Na Azide 
and 1:40 dilutions of tetramethylrhodamine conjugated goat anti-mouse IgGi and 
fluorosceinisothiocyanate conjugated goat anti-mouse IgG2b (Southern Biotechnology 
Associates Inc.). The dishes were again washed 6 times with 1 x PBS and a drop of 
glycerol containing 2.5 mg / ml DABCO [1,4-diazabicyclo(2,2,2)octane; to prevent 
fading of the fluorescence] added. A cover slip was placed over the monolayer and 
sealed at the edges with nail polish, allowing the monolayers to be stored for a few 
days without fading of the fluorescence. 
Fluorescence microscopy was carried out on the RBC monolayers using a Leitz Dialux 
20 microscope with u.v. illumination. Parasites were observed under three different 
filters. Through Leitz filter blocks A, 12 & N2, the blue staining of parasite nuclei by 
DAPI, the red of rhodamine associated with asexuals and the green of fluorescein 
associated with gametocytes, respectively, could be observed. In each monolayer, 
between 50 & 400 parasites (based on DAPI-staining and morphology under white 
light) were counted. Only parasites that were old enough to contain haem pigment 
(detected by white light) were counted, to avoid inclusion of parasites that died at an 
early stage of their development. Parasites that did not contain haem frequently 
expressed the asexual-specific antigen but never the gametocyte-specific antigen, thus 
inclusion of young parasites would under-estimate the proportion of gametocytes if 
mortality in a particular monolayer was higher than normal. Included parasites were 
then observed under the other two filters to determine whether they were gametocytes 
or asexuals. Morphology under white light was used to confirm the phenotype where 
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possible. Given the observed limited cross reactivity of the asexual-specific mAb to 
gametocytes, but not vice versa with the gametocyte-specific mAb, on the occasions 
when both mAbs seemed to react strongly to a parasite, the parasites were determined 
to be gametocytes. The counting of parasites in a monolayer from a chioroquine-
treated culture was carried out at the same sitting as a monolayer from the paired 
control culture, in a randomised order. The number of parasites counted in replicate 
monolayers were combined, to obtain one estimate of the proportion of gametocytes to 
total parasites for each culture. In five experimental culture pairs, only one monolayer 
per culture was assayed. 
Statistical analysis 
Where appropriate, all response variables were transformed to bring their distributions 
close to normal. All analyses were carried out using GLIM 4. Starting with the 
interactions, terms were removed from the full model by stepwise deletion (Crawley 
1993). Non-significant terms were pooled with the residual deviance to obtain the 
error deviance. Significance of terms was determined from F-ratios of the deviance 
explained by each term to the error deviance. 
The effect of chloroquine on gametocyte production was analysed by logistic 
regression using a binomial error structure (heterogeneity factor = 3.2; the ratio of 
residual deviance to degrees of freedom after all non-significant terms had been 
removed) with number of gametocytes used as the numerator and the sum of 
gametocytes and asexuals as the denominator (Crawley 1993). The analysis was 
carried out using a split-plot design (Sokal & Rohlf 1995). TREATMENT 
(chloroquine+, chioroquine-) was fitted within-EXPERIMENT (pairs of cultures, 
'plot', of which there were 6 or 7 per clone) and CLONE (3137, HB3, 7G8 & 
SUD 124/8) fitted as a between-EXPERIMENT factor. Between EXPERIMENT 
differences in the proportion of gametocytes to total parasites were very large. These 
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differences are however of little biological interest and are not reported in this and 
subsequent analyses where TREATMENT was fitted within-experiment. 
The effect of chioroquine on asexual growth was analysed by ANOVA of square-root 
arcsin-transformed asexual parasitaemia (asexual parasites I RBC) 2 days post-
treatment, with TREATMENT fitted within-EXPERIMENT, and CLONE fitted 
between-EXPERIMENT. Asexual parasitaemia 2 days post-treatment represented the 
population of parasites after having undergone one more round of replication, and was 
thus the most appropriate time point to measure inhibition of asexual growth. 
In determining clone differences in the effect of chloroquine on gametocyte 
production, it is important to know whether clones differed in gametocytogenesis in 
the absence of chloroquine. This was determined by analysis of only untreated 
cultures. Because of over-dispersion in the data, proportion of gametocytes to total 
parasites were square-root arcsin-transformed, and analysed by ANCOVA with 
CLONE fitted as a factor and angular-transformed asexual parasitaemia on day 0 
(when commitment of the progeny to gametocyte and asexual development likely took 
place) fitted as a covariate. 
The effect of chioroquine-induced destruction and / or growth inhibition of asexual 
parasites on investment into gametocytes was analysed by ANCOVA, with the 
response variable being, 
(1), 
(a + b) /2 
the difference between proportion of gametocytes in chloroquine-treated (a) and the 
paired untreated culture (b) (standardised by dividing by the mean proportion of 
gametocytes within-pair, to control for the large differences in proportions of 
gametocytes between experiments). CLONE was fitted as a factor and the 
standardised difference between asexual parasitaemia (2 days post-treatment) of 
untreated (a) and chioroquine-treated cultures (b) (see equation 1) fitted as a covariate. 
Actual chloroquine concentrations were not used as the covariate, because the effect on 
asexual inhibition of a given concentration is dependent on overall asexual parasitaemia 
(Gluzman et at. 1987). 
Differences in successful binding of mAbs between chioroquine-treated and untreated 
cultures was analysed by logistic regression using a binomial error structure 
(heterogeneity factor = 4), with the number mAb- (and DAPI-) positive parasites used 
as the numerator and the number of DAPI-positive parasites as the denominator. 
TREATMENT was fitted within EXPERIMENT, and CLONE fitted between-
EXPERIMENT. 
6.4 RESULTS 
Two days after the addition of chioroquine to cultures, asexual parasitaemias were on 
average 40 % that of paired control cultures (figure 6.2, table 6.1). The effect of 
chioroquine on asexual parasitaemia did not differ between clones (figure 4.2, table 
6.2). 
Between-experiment 
Clone 	 F322 = 1.9 
Within-Experiment 
Treatment 	F 125  = 69.2* 
Clone x treat. F322 = 2.56 
Table 6.1: Results of analysis of the effect of chloroquine on asexual parasitaemia 
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The greater the asexual parasitaemia in untreated cultures prior to invasion of the 
monolayer (day 0), the greater the proportion of parasites that subsequently developed 
into gametocytes (figure 6.3, table 6.3). Neither the relationship between proportion 
of gametocytes and asexual parasitaemia, or proportion of gametocytes differed 
between clones (figure 6.3 & 6.4, table 6.3). 
Asexual parasitaemia 	F 121  = 6.12* 
Clone 	 F321 = 0.18 
Asex. x clone 	 F318 = 2.77 
Table 6.3: Results of the analysis of the effect of asexual parasitaemia in untreated 
cultures (at the time monolayers were overlaid) on the subsequent proportion of 
gametocytes in the monolayer. * p < 0.05 
Experiment number 
Figure 6.2: Asexual parasitaemias 2 days post-treatment for all clones. Data are 
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Figure 6.3: The relationship between proportion of parasites that developed into 
gametocytes in the RBC monolayer and asexual parasitaemia on day 0 (time of 
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Figure 6.4: Mean (+1 s.e) proportion of parasites that developed into gametocytes 
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In all experiments, the proportion of gametocytes to total parasites was greater in 
monolayers from chloroquine-treated compared to untreated cultures, on average a 5-
fold increase across all experiments (figure 6.5, table 6.4). The effect of chloroquine-
treatment on proportion of gametocytes differed between clones (table 6.4). 
Between-experiment 
Clone F322 = 1.3 
Within-Experiment 
Treatment F 1 , 25 = 81.3 **  
Clone x treat. F322 = 43* 
Table 6.4: Results of analysis of the effect of chloroquine on the proportion of 
parasites that were gametocytes in the monolayers. *p  <0.05;  **p  <0.0001. 
Experiment number 
Figure 6.5: Proportion of parasites that developed into gametocytes in the RBC 
monolayer for all clones. Data are shown in culture pairs (experiments). CQ; 
chloroquine. 
The level of gametocytogenesis induced by chioroquine treatment increased with the 
extent of chioroquine-induced asexual grwoth inhibition (figure 6.6, table 6.5). For a 
given value of relative asexual growth inhibition, proportions of gametocytes in 
chloroquine-treated cultures relative to untreated cultures were more than 2 times 
greater in clones 3D7 and 124/8 than HB3 and 7G8 (figure 6.6, table 6.5). 
Asexual inhibition 	F 121  = 22.89** 
Clone 	 F 123  = 11.4* 
Asex. x clone 	 F318 = 1.6 
Table 6.5: Results of the analysis of the effect of asexual growth inhibition (in 
chloroquine-treated cultures relative to untreated cultures) on the increase in the 
proportion of gametocytes in monolayers from chloroquine-treated cultures relative to 
untreated culture. Clone could be simplified to from a four- to a two-level factor, 
without a significant increase in deviance. * p <0.01; **p  <0.001. 
Successful mAb detection (the percentage of DAPI-positive parasites that were also 
TRITC- or FITC-positive) were 79 % and 85 % for the progeny of chloroquine-treated 
and untreated cultures, respectively (table 6.6). Even if the additional 6% of 
undetected parasites in chloroquine-treated cultures were all asexual parasites, this 
would not qualitatively change the results. Detection did not differ between clones, 
nor did the effect of treatment on detection differ between clones (table 6.6). 
Between-experiment 
Clone F322 = 0.48 
Within-Experiment 
Treatment F 125  = 10.42* 
Clone x treat. F322 = 1.83 
Table 6.6: Results of analysis of succesful mAb detection. *p  <0.01. 
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Figure 6.6: The relationship between the relative increase in gametocytogenesis and 
inhibition of asexual growth following chioroquine treatment (see text). The upper 
line is the ordinary least-squares regression line for 3137 and SUD12418, the lower for 
HB3 and 7G8. CQ-sensitive and -resistant clones are shown by open and filled 
symbols, respectively. 
6.5 DISCUSSION 
The results demonstrate that sub-curative chioroquine treatment increases 
gametocytogenesis in P. falciparum (figure 6.5). P. falciparum, like P. chabaudi 
(Buckling et al. 1997, chapters 2 and 4) appears to increase its investment into 
gametocytes when conditions are unfavourable for asexual growth. Such a response 
is presumably adaptive in that it is likely to increase transmission from harsh 
environments. 
In all clones, gametocytogenesis increased with increasing inhibition of asexual 
growth. There were genetic differences in this relationship, with two clones (3D7 and 
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SUD124/8) showing a more than 2-fold increase in gametocytogenesis, for a given 
level of drug efficacy, than the other two clones (HB3 and 7G8). That 
gametocytogenesis did not differ between clones when untreated (figure 6.4) suggests 
that the observed clone differences in the relationship between chloroquine-imposed 
stress and gametocytogenesis represent differences in sensitivity to environmental 
stress. 
These differences were independent of drug resistance (figure 6.6): 3D7 & HB3 are 
chioroquine-sensitive, and SUD124/8 & 7G8 are chioroquine-resistant. Unlike 
previous field reports (Handunnetti et al. 1996, Robert et al. 1996), there was also no 
difference in gametocyte production of untreated chioroquine-resistant and -sensitive 
clones. It therefore appears that chioroquine-imposed selection per se has not 
modified P. falciparum gametocytogenesis, either intrinsically or in response to 
chioroquine. This supports the hypothesis that increased gametocyte production is a 
general response to retarded asexual growth in unfavourable conditions, with 
chloroquine treatment being an example of such. Consistent with previous data 
(Carter & Miller 1979, Brockelman 1982, Bruce et al. 1990), increased resource 
competition, through increased asexual parasitaemia, resulted in increased 
gametocytogenesis, when all the data was considered. Probably because of small 
sample sizes for each individual clone, this trend was not apparent for clones 3D7A 
and 7G8 (figure 6.3). 
Demonstration of chioroquine-enhanced gametocyte production in vivo in P. chabaudi 
(Buckling et al. 1997, chapters 2 and 4) and in vitro in P.falciparum strongly suggests 
that the phenomenon may be widespread. Given the positive relationship between 
gametocyte densities and infectivity to mosquitoes (Carter & Graves 1988, Taylor & 
Read 1997, Taylor et al. 1997, Buckling et al. 1997, chapter 2), such compensatory 
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increases in gametocyte production may help to explain the relative ineffectiveness of 
chloroquine chemotherapy, which is frequently sub-curative (Wernsdorfer 1994), to 
reduce malaria transmission. Increased P. falciparum gametocyte production is 
induced by a wide variety of stresses (Mons 1985, Carter & Graves 1988, Sinden et 
al. 1996), including a variety of antimalarial drugs in P. chabaudi (Buckling etal. 
1997, chapters 2 and 4). It may be that any intervention strategy that inhibits asexual 
growth, including most methods of sub-curative antimalarial treatment and 
prophylaxis, as well as potential blood-stage vaccines, may induce compensatory 
increases in transmission stage production by the parasites. 
102 
Chapter 7 
ANTIMALARIAL INTERVENTION AND THE 
EVOLUTION OF PLASMODIUM VIRULENCE 
7.1 SUMMARY 
Experiments were carried out to determine the effects of partially protective immunity 
and antimalarial drug prophylaxis (drug administered before infection) on virulence, 
within-host parasite replication and transmission of the rodent malaria parasite, 
Plasmodium chabaudi, in vivo. Both methods of intervention reduced virulence 
relative to control infections. Virulence was less in animals challenged with the 
immunising genotype rather than a different genotype. Strong positive correlations 
were found between within-host parasite replication and virulence (measured by host 
anaemia), and parasite replication and the number of transmission stages (gametocytes) 
produced by the parasite. The relationship between virulence and transmissability did 
not differ from control infections, except transmission for a given level of parasite 
replication (and virulence) was increased in drugged infections. These data suggest 
that both selection for increased transmission and competitive ability within-hosts may 
be important determinants of the evolution of virulence in malaria parasites. It is 
speculated that the use of intervention strategies is likely, if anything, to select for a 
reduction in parasite virulence. The study also highlights the significance of separate 
parasite stages for within-host replication and transmission on the evolution of 
virulence. 
7.2 INTRODUCTION 
Disease virulence (defined as the reduction in host fitness) is generally believed to be 
the result of selection optimising parasite transmission success (Bull 1994, Read 1994, 
Frank 1996, Ebert & Herre 1996, Lipsitch & Moxon 1997). Most models of the 
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evolution of microparasite virulence assume that virulence per se is detrimental to 
parasite fitness, but is the unavoidable consequence of selection for increased 
transmission (the 'adaptive trade-off' models, e.g. Levin & Pimentel 1981, Anderson 
& May 1982, Bremermann & Pickering 1983). This is because of an assumed 
positive correlation between within-host parasite replication rate and both transmission 
and virulence. When virulence reaches a certain level, the costs of virulence (usually 
assumed to be host mortality) are greater than the benefits resulting from increased 
transmission. Transmission will thus be maximised at an intermediate level of 
virulence. 
Most forms of anti-parasite intervention (for example chemotherapy and vaccination) 
directly inhibit parasite replication, resulting in a reduction in transmission. This 
reduction in transmission might result in selection for increased parasite replication and 
thus increased virulence if the parasite infects individuals not exposed to the 
intervention (Read 1994). How the intervention extrinsically affects the relationship 
between within-host replication and transmission, and replication and virulence is also 
likely to affect how selection will act on within-host replication (Frank 1996): 
changing these relationships will affect the costs and benefits of a given level of 
within-host replication. For example, if an intervention strategy caused per parasite 
virulence to decrease, there will be a reduction in the cost (e.g. host mortality) of a 
given level of within-host replication. As a result, the level of within-host replication 
which balances the cost and benefits to transmission will be increased. If selection 
acts on asexual replication in this way, the parasite might then be more virulent in 
hosts not exposed to the intervention (figure 7.1). 
Inferring selection pressures from phenotypic data, as is being attempted here, requires 
that the phenotypic changes resulting from the environmental changes are non-
transitory. That is, the phenotypic relationships between traits in a particular 
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environment are assumed to be indicative of underlying genetic relationships. 
Phenotypic plasticity in the relationships between relevant traits or short-term 
acclimation (Leroi et al. 1994) to changing environmental conditions would render 
inferred selection pressures from short-term phenotypic data relatively meaningless. 
These problems aside, a phenotypic approach to understanding the evolution of life 


















Figure 7.1: (a) Some form of anti-parasite intervention extrinsically alters the 
relationship between within-host parasite replication and virulence from x 2 to x 1 . 
Potential transmission is directly proportional to parasite replication rate. (b) Actual 
transmission is the product of potential transmission and the 'cost of virulence'; the 
probability of host survival in this case. The replication rate that maximises 
transmission (shown by the arrows) is increased under the intervention strategy. If the 
intervention is very widespread and their exists genetic variation in replication rates, 
the change in the relationship between parasite replication and virulence caused by the 
intervention may select for an increase in parasite replication rate. As a result, the 
virulence of this parasite will be greater in individuals not exposed to the intervention. 
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Both genetic and phenotypic positive correlations have been found between virulence 
(as measured by host anaemia and weight loss) and the density of asexually replicating 
blood-stage parasites of the rodent malaria parasite, Plasmodium chabaudi (Taylor et 
al. 1998, Mackinnon & Read, submitted). Parasite densities also showed a positive 
genetic correlation with transmission to the mosquito vector (Taylor et al. 1998, 
Mackinnon & Read, submitted). This is consistent with the assumptions necessary for 
selection to act as expected in the 'adaptive trade-off models' (Levin & Pimentel 1981, 
Anderson & May 1982, Bremermann & Pickering 1983). Moreover, genetic variation 
in asexual replication rates (Mackinnon et al. submitted) would allow selection to act if 
the optimal level of replication is extrinsically altered by antimalarial intervention. 
It is likely that some forms of antimalarial intervention could extrinsically alter the 
relationships between asexual replication, transmission and virulence, although 
existing data are very ambiguous. For example, although the virulence of malarial 
infections generally shows a positive relationship with parasite densities, some of the 
pathology is proximately caused by the immune system (Houba 1988). As a result, 
partial host immunity generally results in a decrease in virulence for a given parasite 
density (McGregor & Wilson 1988). 
I carried out experiments to determine how immunisation (previous exposure to a 
malarial infection) and antimalarial prophylaxis (drugs administered before infection) 
affected virulence of the rodent malaria parasite P. chabaudi in laboratory mice. 
Immunity against P. chabaudi is in part genotype-specific (McLean et al. 1982, Jarra 
& Brown 1985, Jarra et al. 1986, Bates et al. 1988, chapter 5). Asexual densities are 
lower when the same genotype is used for immunisation and subsequent challenge 
(homologous challenge), than if the immunising and challenge genotypes differ 
(heterologous challenge). I wanted to determine whether the virulence of infections in 
immunised hosts was similarly genotype-specific. I also determined how prophylaxis 
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and immunisation affected the relationships between asexual replication, transmission 
and virulence. Any changes in these relationships might give an indication of how 
selection resulting from the intervention might act on parasite virulence, assuming 
phenotypic correlations are indicative of underlying genetic correlations. All 
intervention was necessarily partially protective: asexual replication was inhibited, 
without preventing it all together. For ethical and practical reasons, anaemia, rather 
than host mortality was used as the measure of virulence. Plasmodium chabaudi is 
generally non-lethal in the inbred strain of mice used in these experiments. However, 
in less resistant strains, host mortality is positively correlated with anaemia (Stevenson 
et al. 1982, Yap & Stevenson 1992, 1994). Moreover, anaemia is itself a severe 
morbidity factor of malarial infections. 
7.3 MATERIALS AND METHODS 
Parasitology 
Chemotherapy and immunisation experiments were carried out separately. Details of 
methods can be found in sections 3.3 and 6.3, respectively. In summary, male 
C57/BL/6J mice were infected with lx 106  P. chabaudi parasites of a single genotype 
(either clone CR or ER). This strain of mice is partially resistant to P. chabaudi 
infections (Stevenson et al. 1982). In the chemotherapy experiments, mice were 
administered with sub-lethal doses (to the parasite) of either chloroquine or 
pyrimethamine approximately 1 hour before parasite inoculation. Control mice were 
given distilled water or DMSO, depending on the solvent used for the drugs in each 
experiment. In the immunisation experiments, mice were infected with lxi o parasites 
(either clone CR or ER), with infections cleared by curative mefloquine treatment 4 
days later. Control animals received equivalent inoculations of uninfected red blood 
cells (RBCs) and the same drug treatment. Mice were challenged 4 weeks after 
parasite clearance with the either the same (homologous challenge) or different 
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(heterologous challenge) clone as used for immunisation. Details of experiments can 
be found in tables 4.1 and 5.1. 
Numbers of asexual parasites and gametocytes per RBC were counted from Giemsa-
stained thin blood smears, approximately every second day. RBC densities were 
measured by flow cytometry every second day. Parasite densities were determined by 
multiplying parasites I RBC by RBC density. 
Statistical analyses 
Three types of measures were determined for each infection: virulence, within-host 
asexual replication and transmission. Virulence was estimated from both minimum 
and mean RBC densities (Taylor et al. 1998). Note that these traits are actually 
negatively correlated with virulence. Asexual replication was measured in 5 ways: (i) 
total parasites produced during the entire infection was determined by integrating under 
parasite density through time curves. This will be a reasonably accurate estimate, 
given the 24 hour asexual cycle of P. chabaudi (Cox 1988). (ii) peak asexual 
parasitaemia (asexuals / RBC), (iii) peak asexual density, (iv) rate of increasing 
parasitaemia, and (v) rate of increasing parasite density. These latter two measure 
were determined by dividing the peak asexual parasitaemia and density, respectively, 
by the day post-infection the peaks were reached. 
Total transmission of an infection is likely to be determined by the number of 
gametocytes produced during the entire infection (Taylor & Read 1997). Integration 
under the density through time curves is a reasonable approximation of total 
gametocytes. The half-life of P. chabaudi gametocytes is less than 12 hours, and 
measures were taken every second day, thus very few gametocytes would survive 
from one day's measurement to the next. 
All analyses was carried out using GLIM 4. Chemotherapy and immunisation 
experiments were analysed separately. Where appropriate, all measures were 
transformed to bring their distributions close to normal (total asexuals, peak asexual 
density, rate of increasing parasite density and total gametocytes were log 10-
transformed, peak asexual parasitaemia and rate of increasing parasitaemia were 
square-root arcsin-transformed). The effect of asexual replication on each virulence 
measure was determined by ANCOVA, with all the asexual replication covariates, 
EXPERIMENTAL BLOCK and TREATMENT (drug+, drug- in the chemotherapy 
experiments; non-immune, homologous and heterologous challenge in the 
immunisation experiments) and CLONE (CR or ER; immune experiments only) fitted 
as factors. CLONE was not included as a factor in the prophylaxis experiments, as the 
two clones were never used in the same block. 
The effect of TREATMENT, BLOCK and CLONE (immune experiments only) on 
transmission and virulence measures, independent of relevant covariates, was 
determined by ANOVA. The effect of genotype-specific immunity on virulence and 
transmission was determined by ANOVA using only immunised animals, with 
IMMUNISING CLONE (ER or CR), CHALLENGE CLONE (ER or CR) and 
EXPERIMENT fitted as factors. Detection of a significant interaction between the 
immunising clone and the challenge clone is evidence for strain-specific immunity 
(Read & Viney 1996). 
The significance of terms was determined by stepwise deletion, starting with the 
highest order interactions (Crawley 1993). Non-significant terms were removed from 




Both mean and minimum RBC densities were greater in drugged than control animals 
(figure 7.2, table 7.1). Rate of increasing parasitaemia showed the best (negative) 
relationship with both mean and minimum RBC densities out of all the asexual 
replication measures, explaining 60 % of the deviance in mean RBC density (figure 
7.3a, table 7. 1), and 32 % of the deviance in minimum RBC density (figure 7.3b, 
table 7.1). None of the other asexual replication covariates explained a significant 
amount of additional deviance. Differences in both mean and minimum RBC densities 
between treatments could be explained by differences in asexual replication (figure 
7.3a & b, table 7.1). 
Rate of increasing parasitaemia also showed the strongest (positive) relationship with 
total gametocytes, explaining 50 % of the total deviance (figure 7.3c, table 7. 1), which 
was not significantly increased by the addition of any of the other asexual replication 
measures (p > 0. 1, in all cases). However, at the mean rate of increasing 
parasitaemia, drugged infections produced 1.9 times more gametocytes than control 
infections (figure 7.3c, table 7.1). As a result, total gametocytes did not significantly 
differ between drugged and control infections (table 7.1). 
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Table 7.1: Minimal models for the ANOVAs and ANCOVAs for the drug 
prophylaxis experiments. Interaction terms were removed, as all were non-significant 
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Figure 7.2: Mean (± 1 s.e.) RBC densities throughout infections of control and 
drugged animals 
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Figure 7.3: Trait relationships from chemotherapy experiments. Relationships 
between square-root arcsin-transformed rate of increasing asexual parasitaemia 
(asexual replication) and: (a) mean RBC density, (b) minimum RBC density (both 
measures of virulence) (c) log o-transformed total gametocytes (transmission). Lines 
show significant (p <0.05) ordinary least squares regressions. 
Immunisation 
Both mean and minimum RBC densities were higher in immunised compared with 
control animals (figure 7.4, table 7.2). Mean RBC densities were higher in 
immunised animals that were challenged with the homologous compared to the 
heterologous clone (figure 7.5, table 7.2, IMMUNISING CLONE by CHALLENGE 
CLONE interaction: F 124 = 12.57, p  <0.01), although there was no difference in 
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minimum RBC densities (table 7.2, IMMUNISING CLONE by CHALLENGE 
CLONE interaction F 126 = 1.94, p > 0.1). Peak asexual parasitaemia negatively 
correlated with mean RBC density, explaining 40 % of the deviance (figure 7.6a, table 
7.2); more than the other asexual replication covariates, which did not explain a 
significant amount of additional deviance (p > 0. 1, in all cases). Peak asexual 
parasitaemia explained 26 % of the minimum RBC density deviance (figure 7.6b, table 
7.2). A significant amount (approximately 10 %) of additional minimum RBC density 
deviance was explained by total asexuals (table 7.2). Differences in virulence between 
treatments could be explained by differences in asexual replication between treatments 
(figure 7.6a & b, table 7.2). 
Total gametocytes were higher in control compared with immunised mice (table 7.2), 
with no significant difference in total gametocytes between immunised animals that 
were challenged with the homologous or heterologous clone (IMMUNISING CLONE 
by CHALLENGE CLONE interaction: F 123 = 1.42, p  <0.1). Total asexuals 
positively correlated with total gametocytes, explaining 36 % of the deviance 
associated with total gametocytes (figure 7.6c, table 7.2); more than the other asexual 
replication covariates, which did not explain a significant amount of additional 
deviance (p> 0. 1, in all cases). Differences in total gametocytes between treatments 
could be explained by differences in asexual replication (figure 7.6c, table 7.2). 
Clone differences 
Mean and minimum RBC densities were slightly greater in clone CR than clone ER, 
although these differences were not significant (table 7.2). However, the relationship 
between peak asexual parasitaemia and virulence differed between clones: at the mean 
peak parasitaemia, clone CR had mean RBC density 5 % greater, and minimum RBC 
density 20 % greater, than clone ER (table 7.2). Total gametocytes did not 
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significantly differ between clone CR and ER, nor was there a difference between 
clones in the relationship between total gametocytes and total asexuals (table 7.2). 
Mean RBC Mm. RBC Total 
density density gametocytes 
(x iO / ml) (x 10 / ml) (x 106) 
Mean 	(s.e.): 
Control 4.83 (0.13) 2.00 (0.43) 17.45 (3.43) 
Horn. challenge 6.9 (0.18) 3.6 (0.24) 4.4(l.4) 
Het. challenge 6.1 (0.15) 3.2 (0.19) 4.6(l.1) 
CloneCR 6(0.23) 3.1 (0.22) 12.8 (3.9) 
Clone ER 5.8 (0.21) 2.7 (0.2) 6(2.1) 
ANOVA: 
Treatment F238  = 54.1** F240  = 22.2** 
	
2,41 	'-' F2,4 	3.93* 
Clone F 137 = 3.96 F140 = 7•9** F 139 = 1.59 
Experiment F 138 = 1.54 F 139 = 0.65 F 139 = 3.94 
Treat x exp. F138  = 5.62* 
ANCOVA: 
Asex. replication F140  = 159.4** F140 = 22 . 3** 1 F, 42  = 23.48** 
Treatment F238 = 1.65 F238 = 0.54 F238 = 0.2 
Clone F, 40  = 5.18* F 140  = 7.1* F, 38 = 2.46 
Experiment F, 40  = 8.41** F 138 = 1.2 F138 = 0.4 
Table 7.2: Minimal models for the ANOVAs and ANCOVAs for the immunisation 
experiments. Interaction terms were removed when non-significant. * p <0.05; **p 
<0.01. Mm.; minimum. 'An additional within-host replication covariate (total 
asexuals) explained a significant amount of additional deviance (F 1 = 7.34, p < 
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Figure 7.4: Mean (± 1 s.e.) RBC densities throughout infection of control and 
immunised animals. Homologous and heterologous challenge refer to whether the 
challenge genotype was the same or different to the immunising genotype, 
respectively. 
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Figure 7.5: Mean (± 1 s.e.) RBC densities for immunised animals. ER and CR are 
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Figure 7.6: Trait relationships from immunisation experiments. Relationships 
between square-root arcsin-transformed peak asexual parasitaemia (asexual replication) 
and: (a) mean RBC density, (b) minimum RBC density (both measures of virulence). 
(c) Relationship between 1og 10-transformed total asexuals (asexual replication) and 
1og 10-transformed total gametocytes. Lines show significant (p <0.05) ordinary least 
squares regressions. Homologous and heterologous challenge refer to whether the 
challenge genotype was the same or different to the immunising genotype, 
respectively. 
7.5 DISCUSSION 
Both antimalarial prophylaxis and immunisation resulted in a reduction in the anaemia 
(virulence) caused by infections with P. chabaudi (table 7.1 & 7.2, figures 7.2 & 7.4). 
The reduction in virulence resulting from immunisation was in part genotype-specific: 
mean RBC densities were lower in animals following homologous, compared to 
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heterologous, challenge (figure 7.5), although there was no difference in minimum 
RBC densities. The severity of malarial infections of partially immune animals is thus 
likely to be dependent on whether the animal has been previously infected with the 
current infecting genotypes. This is consistent with data from people infected with P. 
falciparum: the probability of developing clinical symptoms is greater following 
infection with a novel, compared to a previously encountered, P. falciparum genotype 
(Mercereau-Puijalon 1996, Roper et al. 1998). 
Strong positive correlations were found between asexual replication and anaemia 
(virulence), and between asexual replication and total numbers of gametocytes 
(transmission). These phenotypic data support previously reported phenotypic (Taylor 
et al. 1998, Mackinnon & Read, submitted) and, more importantly, genetic 
correlations (Mackinnon & Read, submitted) between these traits in P. chabaudi. All 
these data are consistent with the assumptions necessary for selection to act as 
expected in the 'adaptive trade-off models' (Levin & Pimemtel 1981, Anderson & May 
1982, Bremermann & Pickering 1983). 
Any method of intervention that reduces transmission through a reduction in asexual 
parasite replication will impose strong selection for compensatory increases in asexual 
replication. As a result, the widespread use of chemotherapy and vaccination may 
select for parasites that will have greater virulence in the absence of the intervention 
(Read 1994). This selection pressure might however have negligible effects: selection 
for increased asexual replication is likely to be strong in the absence of intervention, as 
most host populations in malaria-endemic areas have some anti-malarial immunity 
(McGregor & Wilson 1988). As a result, asexual replication and transmission of 
natural malarial infections are considerably reduced compared to infections in non-
immune hosts (James et al. 1936, Landau & Chabaud 1994). These arguments would 
be irrelevant if asexual replication was limited by host mortality, as assumed by the 
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adaptive trade-off models of the evolution of virulence. Host mortality resulting from 
malarial infections is however generally relatively low (people; Targett 1992, rodents; 
Landau & Chabaud 1994, lizards; Schall 1996). If, as suggested, it is the host 
immune system that limits asexual replication, observed levels of virulence of malaria 
parasites are unlikely to be largely the result of parasite adaptation, as assumed by 
most models of the evolution of virulence (Bull 1994, Read 1994, Frank 1996, Ebert 
& Herre 1996, Lipsitch & Moxon 1997). 
The relationship between asexual replication and virulence did not differ between 
control and drugged infections, or control and immunised infections (figures 7.3 & 
7.6). Based solely on these relationships, there is no suggestion that long-term 
changes in virulence would arise as a result of these methods of intervention. In other 
words, both forms of intervention are unlikley to change the optimum level of asexual 
replication. Infections with clone ER were more virulent for a given level of asexual 
replication than infections with clone CR, suggesting parasite (genetic) factors beyond 
net asexual replication are important in determining virulence in Plasmodium. 
No difference was found in the relationships between asexual replication and numbers 
of gametocytes between infections in immunised and control animals (figure 7.6c). 
However, for a given level of asexual replication, numbers of gametocytes were two 
times greater in drugged than control infections. As a result, drugged infections were 
able to produce the same number of gametocytes, but at lower virulence, than in 
control infections (table 7. 1, figure 7.3c). 
Gametocyte /asexual trade-offs and the evolution of virulence 
What can a change in the relationship between virulence and transmission tell us about 
the change in the costs and benefits of virulence resulting from drug prophylaxis? 
Unfortunately, very little. The proportion of asexual parasites that develop into 
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gametocytes can be facultatively increased in response to conditions unfavourable for 
asexual replication (Carter & Graves 1988), including antimalarial chemotherapy 
(Buckling et al. 1997, chapters 2, 4 & 6). The reduction in virulence and asexual 
parasites in the absence of a significant reduction in gametocytes is likely to be the 
result of parasites adaptively increasing their investment into gametocytes (Buckling et 
al. 1997, chapter 2). Inferring selection pressures from a change in the relationship 
between asexual replication and transmission would only be meaningful if these 
phenotypic correlations were indicative of underlying genetic correlations. This is 
clearly not the case if the parasites were facultatively altering the relationship. 
The existence of separate stages for within-host growth and transmission might have 
important implications for the evolution of virulence. Although positive correlations 
are found between asexual replication and transmission, there is also a direct trade-off 
between these traits: the production of a gametocyte, results in an asexual parasite not 
being produced, and vice versa. This may result in a cost to transmission of increased 
asexual replication, additional to other costs, such as increased host mortality. 
Selection for increased asexual replication (through, for example, within-host 
competition between genotypes (Frank 1996)) might be achieved by decreasing 
gametocyte production. Indeed, passaging asexually replicating parasites directly from 
vertebrate host to vertebrate host (in the absence of mosquito transmission) frequently 
results in increased asexual replication and reduced gametocyte production in a variety 
of species of malaria parasites (Carter & Graves 1988, Dearsley et al. 1990). None of 
the models for the evolution of virulence outlined above explicitly consider this trade-
off, yet separate within-host replication and transmission stages are common amongst 
many parasites of medical and veterinary importance, including Trypanosoma, Eimeria 
and Plasmodia. 
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Unfortunately, it is impossible to determine the extent of the impact of reduced 
gametocyte production on asexual replication in the direct passage experiments 
mentioned above: increased asexual replication might have been achieved in other 
ways, such as increased numbers of progeny per parasite, or better immune evasion 
strategies. Similarly, the importance of enhanced gametocyte production on reducing 
asexual replication could not be addressed in the current study, as alteration in the 
relationships between asexual replication and gametocyte production was observed 
under conditions that inhibited asexual replication anyway (antimalarial prophylaxis). 
However, under most assumptions of a recent series of models, changing gametocyte 
production does have a notable impact on asexual parasite densities (Mckenzie & 
Bossert 1998b). 
If fitness of malaria parasites positively correlates with transmission, why don't 
infections in immunised and control animals behave like infections in drugged animals, 
producing more gametocytes for a given level of asexual replication? It is possible that 
this is the result of within-host competition. Theory predicts that within-host 
competition between different conspecific genotypes results in selection for increased 
within-host replication (May & Anderson 1983, Frank 1992, Hellriegel 1992, Nowak 
& May 1994, van Baalen & Sabelis 1995, Frank 1996). Natural P. chabaudi 
infections have frequently been found to consist of more than one genotype (Carter 
1978), thus selection for increased asexual replication through within-host competition 
may have occurred. As P. chabaudi does not appear to facultatively increase asexual 
replication rates in the presence of other genotypes (Taylor et al. 1998), observed 
levels of asexual replication are likely to be partly dependent on the frequency of 
mixed-genotype infections in the field. The effect of within-host selection is therefore 
likely to be apparent in single genotype infections in this study. Additionally, given 
the huge within-host population size of asexual parasites (at least 10 9 on the day of 
peak asexual parasite densities in untreated infections in these experiments), it is 
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possible that considerable genetic variation could be created during the course of a 
single infection. Within-host selection might therefore operate, even if infections are 
generally initiated by genetically homogenous parasites. Stimulating increased 
gametocyte production by antimalarial chemotherapy might have counteracted the 
effects of within-host selection. 
Other possible explanations for the apparent excess of asexual replication (and 
virulence) of control and immunised infections need to be considered. First, our 
estimates of transmission may not be accurate. After clearance of a primary P. 
chabaudi infection (the infections measured in these experiments), parasites 
periodically increase in numbers to detectable levels (recrudescences). Ideally, these 
recrudescences should be considered when calculating the total transmission from a P. 
chabaudi infection, although, as gametocytes are rarely seen in recrudescences (A. 
Read & M. Anwar, unpublished data), they are unlikely to contribute much to the total 
transmission success of the parasite. 
Second, observed levels of virulence may be the result of the parasites experiencing 
novel conditions. P. chabaudi may have been selected in hosts where replication rates 
are suppressed, resulting in excessive and maladaptive rates of asexual replication in 
the current experiments. Infections in the rodent host from which P. chabaudi was 
isolated, T. rutilans, are often chronic and life long (Landau & Boulard 1978), 
suggesting that replication rates will commonly be suppressed by immunity. 
Furthermore, by initiating infections with infected blood, as opposed to natural 
mosquito inoculation, the host has no time to mount an immune response before 
parasites start replicating in RBCs. We might therefore expect to observe adaptive 
relationships between virulence and transmission if asexual replication is inhibited to a 
greater extent than in control infections in these experiments. This appears to occur in 
drugged, but not in immunised, animals. Unless drugged infections approximate 
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natural infections better than unmanipulated infections or infections in immune hosts 
(which seems very unlikely) this hypothesis is unlikely to be an adequate explanation 
of the results. 
High virulence may have direct transmission-enhancing effects. It has been suggested 
that host incapacitation may reduce anti-mosquito defensive behaviour, resulting in 
increased probability of a mosquito obtaining a blood-meal and becoming infected 
(Day & Edman 1983, Day et al. 1983, Ewald 1994). It is debatable whether 
incapacitation would increase the probability of a mosquito successfully obtaining a 
blood-meal under natural conditions. Although a sick animal cannot defend itself so 
well against mosquitoes (Day & Edman 1983), it would probably spend less time out 
of its shelter, reducing its exposure to mosquitoes. 
Field Implications 
If the current results apply to P. falciparum, the interpretations and speculations may 
be of relevance to the understanding of the effects of chemotherapy and vaccination on 
the evolution of virulence of malaria in the field. In short, the use of such intervention 
is unlikely to result in more virulent parasites: selection for increased transmission (and 
thus increased asexual replication and virulence) is likely to be very strong anyway, 
given the high frequency of immune and partially immune individuals. If within-host 
selection is an important determinant of virulence in P. falciparum (infections 
frequently consist of multiple genotypes; Babiker et al. 1994, Ntoumi et al. 1995, Paul 
et al. 1995), intervention strategies are likely to result in selection for reduced 
virulence. A reduction in transmission (through antimalarial intervention) will 
probably reduce the frequency of mixed genotype infections, decreasing within-host 
competition and virulence. If within-host competition, and therefore high virulence, 
also results from the generation of novel mutants during the course of an infection 
initiated by a single genotype, a reduction in within-host population size by 
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intervention strategies may also select for decreased virulence. Selection for changes 
in parasite virulence may not however have a notable impact on the virulence of 
malarial infections in the field. Variation in host immune status, host (genetic) 
resistance and the use of antimalarial intervention are likely to overshadow any genetic 




Discussions relating to the specific studies in this thesis are given in the relevant 
chapters. Here I summarise the main findings of those studies and address some of 
more general issues and questions arising. 
8.1 PRINCIPLE FINDINGS 
Gametocytogenesis increased as a result of chemotherapy-imposed stress. Where 
assessed (for chioroquine-treated infections), infectivity to the mosquito vector 
(Anopheles stephensi) was not decreased as a result of chemotherapy. Similarly, 
chioroquine-treatment increased five-fold the proportion of P. falciparum parasites that 
were gametocytes in vitro. Genetic variation in the relationship between chloroquine-
imposed stress and gametocytogenesis was found in this study, although this variation 
was independent of drug resistance (chapters 2, 4 & 6). 
Chloroquine did not increase the infectivity of P. chabaudi gametocytes to A. 
stephensi (chapter 3). 
Partial immunisation from prior exposure to P. chabaudi parasites resulted in a 
three to four-fold reduction in both asexual parasites and gametocytes. This differed 
from the effect of chemotherapy, which resulted in no, or a disproportionately small 
(relative to asexuals), reduction in gametocytes. Immunity was strain-specific, with a 
greater reduction in parasite densities when the challenge and immunising genotypes 
were the same (homologous challenge), compared to when they differed (heterologous 
challenge). Strain-specific 'transmission-blocking' immunity was also detected, with 
per gametocyte infectivity reduced following homologous challenge, compared with 
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heterologous challenge and control infections, which did not differ in per gametocyte 
infectivity (chapter 5). 
(d) Virulence (as measured by host anaemia) was reduced by both antimalarial drug 
prophylaxis and immunisation; virulence was greater following heterologous 
challenges compared to homologous challenges. No difference in the relationship 
between asexual replication and anaemia was found between control, drugged and 
immunised infections. The relationship between asexual replication and total 
gametocytes produced throughout the infection did not differ between control and 
immunised infections, but more gametocytes were produced for a given rate of asexual 
replication in prophylaxis infections (chapter 7). 
8.2 PLASMODIUM LIFE HISTORIES 
Between- and within-host selection 
Between-host selection on parasites is likely to act to maximise the overall 
transmission of a single-genotype infection from a host (Anderson & May 1982). 
That patterns of gametocytogenesis in unmanipulated hosts are broadly consistent with 
life history theory (which assumes that selection is acting to maximise reproductive 
success) suggests that P. chabaudi life histories are in part the result of between-host 
selection. Increases in gametocytogenesis in response to stress are consistent with this 
interpretation, as are possible decreases in gametocytogenesis when conditions 
decrease per gametocyte infectivity. Moreover, observed levels of virulence may in 
part be the result of between-host selection: given the positive correlations between 
asexual replication, virulence and transmission, virulence appears to be in part the 
necessary consequence of selection acting on transmission (Anderson & May 1982). 
Why don't malaria parasites produce more gametocytes, as they are clearly capable of 
upregulation of gametocytogenesis? Taylor & Read (1997) suggested that above a 
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certain gametocyte density, transmission may not be increased, as a result of mosquito 
mortality and the development of transmission-blocking immunity. Another important 
consideration is the effects of within-host selection. Within-host selection results from 
competition between conspecific genotypes in the host, and is predicted to result in 
increased within-host replication (Frank 1996). If asexual replication is limited by 
certain physiological and biochemical constraints, selection for increased asexual 
replication may result in reduced gametocytogenesis (Mckenzie & Bossert 1998b). 
The relative importance of altering patterns of gametocytogenesis (within realistically 
biological ranges) has yet to be experimentally addressed. 
Selection for increased asexual replication through within-host competition might be an 
additional important determinant of observed levels of Plasmodium virulence (Frank 
1996). It may also explain differences in overall rates of gametocytogenesis between 
infections in immunised and drugged animals. P. chabaudi is likely to be well adapted 
to immune hosts. It is possible that competitive ability (asexual replication) is more 
important to fitness (relative to other genotypes) than further increases in gametocyte 
production. On the other hand, the adaptive response to a novel and harsh stress such 
as sub-curative chemotherapy might be massive upregulation of gametocytogenesis. 
The relative importance of between-host selection (maximising overall transmission 
success from a host) and within-host selection (maximising competitive ability within-
hosts) on Plasmodium life histories has yet to be experimentally addressed. 
Competitive ability within-hosts is likely to be reflected in relative transmission 
success (Bull 1994). However, within-host selection can sometimes be so strong that 
a good within-host competitor is very poor at transmitting ('short-sighted' evolution; 
Levin & Bull 1994). Selection in mixed and single genotype environments (using the 
full life-cycle of the parasite) would address the importance of competition on asexual 
replication and gametocyte production. Comparison of the life histories of the 
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parasites at the start and end of complete infections would address the possibility that 
mutants generated during the course of an infection initiated with a single genotype 
result in within-host competition and selection. 
Phenotypic and genetic life history changes 
What is the relative importance of genetic variation in gametocyte production compared 
with the obvious phenotypic plasticity shown by the parasite for this trait? Appropriate 
selection experiments involving the complete life-cycle of the parasite could address 
this issue. 
Sex and immune evasion 
The occurrence of strain-specific asexual and transmission blocking immunity are 
likely to be a strong selection pressure for the generation of novel genotypes. It is 
possible that this is a major driving force behind the evolution and maintenance of sex 
in Plasmodium (see Gemmill et al. 1997). The importance of sex as an immune 
evasion strategy could be addressed by looking at the relative transmission success of 
recombinant genotypes in hosts previously exposed to one (or both) of the parental 
genotypes. 
8.3 PROXIMATE MECHANISMS 
Gametocyto genesis 
What are the biochemical pathways that result in gametocytogenesis? The relevance of 
'stress' proteins (such as heat shock-like proteins; Motard et al. 1995) might be an 
important area to address given that 'stress' in a variety of forms appears to increase 
gametocytogenesis (Carter & Graves 1988). Consideration of possible cell surface 




The degree of host anaemia could be largely explained by net asexual replication rates 
in this thesis. However, different clones resulted in different levels of anaemia for a 
given parasite density. What other parasite factors are responsible for the general 
morbidity resulting from a malarial infection? Associations have been made between 
certain parasite traits and specific clinical symptoms (e.g. Rowe et al. 1995), but what 
other parasite factors are responsible for the general morbidity resulting from malarial 
infections? 
8.4 RELEVANCE TO THE FIELD 
The combination of results from the studies on P. chabaudi in vivo and P. falciparum 
in vitro suggest that chemotherapy which acts against asexual parasites, unless used 
curatively, is unlikely to have a very large impact on transmission. A frightening 
possibility is that it may actually increase transmission under some circumstances. 
Although (like previous reports) we found no convincing long-term gametocyte 
infectivity-enhancement following chloroquine treatment, the possibility that it might 
occur makes the need for further work imperative. Both these issues need to be 
addressed in the field, although there would of course be major ethical problems if 
appropriately controlled experiments were carried out. 
Partial immunisation greatly reduced both transmission and virulence, suggesting even 
relatively ineffective vaccines may be of considerable use. The finding that gametocyte 
infectivity-reducing immunity is also strain-specific needs to be further addressed. 
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Adaptive changes in Plaimodium transmission strategies 
following chloroquine chemotherapy 
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AND ANDREW F. READ 
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Edinburgh E119 3JT, UK 
SUMMARY 
Both theory and data suggest that malaria parasites divert resources from within-host replication to the 
production of transmission stages (gametocytes) when conditions deteriorate. Increased investment into 
transmission stages should therefore follow subcurative treatment with antimalarial drugs, but relevant 
clinical studies necessarily lack adequate control groups. We therefore carried out controlled experiments 
to test this hypothesis, using a rodent malaria (Plasmodium chabaudi) model. Infections treated with a 
subcurative dose of the antimalarial chioroquine showed an earlier peak and a greater rate of gametocyte 
production relative to untreated controls. These alterations led to correlated changes in infectivity to 
mosquitoes, with the consequence that chloroquine treatment had no effect on the proportion of 
mosquitoes infected. Treatment of human malaria commonly does not result in complete parasite 
clearance. If surviving parasites produce compensatory increases in their rate of gametocyte production 
similar to those reported here, such treatment may have minimal effect on decreasing, and may actually 
increase, transmission. Importantly, if increased investment in transmission is a generalized stress 
response, the effect might be observed following a variety of antimalarial treatments, including other 
drugs and potential vaccines. Similar parasite life history counter-adaptations to intervention strategies 
are likely to occur in many disease-causing organisms. 
1. INTRODUCTION 
Strategies of resource allocation that maximize fitness 
can differ between benign and stressful environments. 
Consequently, natural selection often favours pheno-
typic alteration of reproductive effort in response to 
stress (Minchella & LoVerde 1981; Crowl & Covich 
1990; Roff 1992; Stearns 1992). In disease-causing 
organisms, such adaptive alterations could render 
intervention strategies against parasitic diseases less 
effective than anticipated. During the course of an 
infection, malaria parasites (Plasmodium spp.) are 
capable of modulating the proportion of replicating 
parasites (asexuals) that develop into non-replicating 
transmission stages (gametocytes). If this modulation 
is stress-induced, medical interventions, such as 
chemotherapy, could lead to greater investment in 
gametocyte production, thus offsetting much of the 
transmission-reducing benefits of killing parasites. 
Here we test this idea experimentally using a rodent 
malaria—mouse model. 
Extrapolating from metazoan life history studies, 
there are two reasons to expect that malaria parasites 
will switch investment from asexuals to gametocytes 
when conditions deteriorate. First, increased repro-
ductive effort should occur following cues associated 
with decreased probability of future survival or 
reproduction. For example, enhanced egg production 
has been demonstrated in snails following exposure to  
castrating trematode infections (the 'fecundity com-
pensation' hypothesis; Minchella & LoVerde 1981). 
Increased investment by malaria parasites into gameto-
cytes should therefore occur in response to environ-
mental cues associated with the decline in future 
transmission potential, such as clearance of the 
infection or the onset of transmission-blocking im-
munity (Koella & Antia 1995; Taylor & Read 1997). 
Second, if conditions change such that one life history 
stage becomes relatively more vulnerable than another, 
increased investment into the least vulnerable stage is 
predicted (the 'safe harbour' hypothesis; Shine 1978). 
In the Jerusalem artichoke (Helianthus tuberosus L.), for 
example, inhibition of sexual reproduction by re-
moving flowers results in increased investment in 
asexual reproduction via tuber development (Westley 
1993). If conditions become less favourable for asexuals 
relative to gametocytes (for example as stage-specific 
immunity develops), increased investment into trans-
mission is again predicted. 
The environmental cues that stimulate gametocyte 
production (gametocytogenesis) are poorly understood 
(Sinden 1983; Carter & Graves 1988; Alano & Carter 
1990), but there is some evidence that the rate of 
gametocyte production increases in response to con-
ditions unfavourable for asexual replication. P. falci-
parum (the most common and virulent human malaria 
parasite) produces more gametocytes in vitro when 
there is a high density of parasitized red blood cells 
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(Carter & Miller 1979; Brockelman 1982; Bruce et at. 
1990). By definition, antimalarial drugs acting against 
blood-stage parasites impose considerable stress, and 
some also have a greater inhibitory effect on asexual 
parasites than on gametocytes. Increased gametocyto-
genesis following treatment that greatly reduces para-
site numbers is therefore to be expected. However, here 
the evidence is more ambiguous. 
Early in vivo clinical trials with human Plasmodium 
frequently reported more gametocytes following treat-
ment with drugs inhibiting folate metabolism and 
hence DNA synthesis (e.g. paludrine, pyrimethamine 
and the sulphonamides; Findlay et at. 1946; Mackerras 
& Ercole 1948; Shute & Maryon 1951; Foy & Kondi 
1952; Ramakrishnan et at. 1952; McCarthy & Clyde 
1973). More recently, increased gametocyte pro-
duction has also been reported in P. falciparum 
infections following treatment with Fansidar, a syn-
ergistic combination of pyrimethamine and sulpha-
doxine (Tin & Nyunt-Hlaing 1984; Marwoto et at. 
1986). However, these increases occurred more rapidly 
than the 8-10 day maturation period of P.fatciparum 
gametocytes (Smalley 1976; Jensen 1979), and other 
studies using Fansidar with longer follow-up periods do 
not support the hypothesis (Strickland et at. 1986; 
Hogh et at. 1995). With other blood-stage anti-
malarials, such as chloroquine or quinine, most clinical 
studies have found no increases in gametocytogenesis 
following subcurative treatment (e.g. Mackerras & 
Ercole 1949 a; Jeffery et at. 1956; Jeffery 1958; Hogh et 
at. 1995). These data have given rise to the con-
ventional wisdom that only drugs which inhibit DNA 
synthesis are capable of inducing increased gameto-
cytogenesis (Carter & Graves 1988; Alano & Carter 
1990), even though there may be exceptions (Mack-
erras & Ercole 1949b). 
But all these data have a common problem: 
chemotherapy may have been used when increases in 
gametocyte production would have occurred anyway. 
This is particularly likely if the conditions stimulating 
both gametocytogenesis and symptoms (and hence 
treatment) approximately coincide, as would be the 
case if, for example, high parasite densities or host 
stress were a common trigger. Understandably, no 
studies included appropriate untreated control infec-
tions, so that the effect of subcurative antimalarial 
chemotherapy on gametocyte production has yet to be 
resolved. 
If enhanced gametocytogenesis can occur following 
subcurative treatment, reductions in infectivity might 
not be nearly as great as reductions in morbidity. This 
may have implications for malaria control and epi-
demiology, particularly if increased gametocytogenesis 
is a generalized stress response stimulated by a variety 
of treatments. We therefore carried out controlled 
experiments using a P. chabaudi—mouse model to test 
the life history prediction of increased gametocyto-
genesis following subcurative chloroquine chemo-
therapy, and to determine any impact on subsequent 
infectivity to a mosquito vector. Chloroquine (CQ) 
was used because of its wide availability in malaria-
endemic areas and the general view that its use does 
not result in increased gametocytogenesis (Carter & 
Graves 1988; Alano & Carter 1990). In addition, it 
only affects asexual parasites and immature gameto-
cytes (Smalley & Sinden 1977), so that increased 
gametocytogenesis might be expected on account of 
both the fecundity compensation and safe-harbour 
hypotheses. 
2. MATERIALS AND METHODS 
Parasites and hosts 
Male C57/BL/6J mice (Harlan-Olac, England) aged 8-14 
weeks were infected with 1 x 10 6  red blood cells infected with 
a CQ-naive P. chabaudj clone (either CR or ER, from the 
WHO Registry of Standard Malaria Parasites maintained at 
the University of Edinburgh, UK) in a 0.1 ml intraperi-
toneal inoculum of 50% Ringer's solution (27 mM KCI, 
27 mM CaCl 2 , 0.15 M NaCI), 45% heat-inactivated calf 
serum and 5% 200 units m1' heparin solution. Mice, 
age-matched within experiments, were housed in cages of 2-4 
animals at a temperature of 25±1 °C with a 0700 to 1900 
hours light cycle, and provided with 41B rat and mouse 
maintenance diet (Harlan-Tekiad, England) and water 
containing 0.05% pABA, ad libitum. 
CQpreparation and administration 
CQ solution was prepared from a stock of 40 mg m1' CQ 
sulphate (NivaquineTM) diluted in distilled water and 
administered orally using a lubricated catheter in approxi-
mately 0.1 ml doses of 12 mg kg of mouse weight in all 
cases. Preliminary experiments revealed this dose to be 
subcurative. Control mice were given 0.1 ml distilled water. 
All treatment took place between 1600 and 1700 hours. 
Parasite counts 
From day 4 post-infection (p.i.), daily thin blood smears 
from the tail vein were Giemsa-stained and asexual parasites 
counted per 1.5 x 10 red blood cells (RBCs). At low asexual 
densities, parasites were counted per I0 RBCs. Mature 
gametocytes were counted per 1.25 x 10 RBCs. Parasite 
densities were calculated from RBC densities, measured by 
flow cytometry (Coulter ElectronicsTM) every second day, 
multiplied by parasites per RBC. 
Mosquito feeds and dissections 
Mice were anaesthetized by an intramuscular injection of 
0.5 ml per 20g mice 3:2:1 distilled water: Vetalar rM : 
RompunTM, and placed onto pots covered with nylon mesh 
containing about 40 4-5 day-old female Anopheles stepliensi, 
which had been starved for the previous 24 h. Mosquitoes 
Table 1. Details of experiments 
no. of mice infected 
clone day p.1. of 
experiment used CQ treatment CQ 	control 
1 	CR 6 6 5 
2 CR 5 6 6 
3 	CR 4 51 
5 6 6 
6 5J 
4 	ER 5 6 6 
p.i., post-infection; CQ, chloroquine. 
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Figure 1. Mean asexual parasite densities (+ 1 s.c.) during infections for experiments 1-4 (a-d respectively). 
CQ, chloroquine. 
were left to feed in the dark for 30 mm, between 1845 and 
1945 hours. They were subsequently maintained at 25-30 °C, 
70-80% humidity, with a 12-h light cycle, and provided 
with 5% glucose, 0.05 % pABA solution ad libitum. After 
8-9 d, approximately 25 mosquitoes per mouse were dissected 
to determine the presence of oocysts on midguts. 
Experiments 
Details of individual experiments are shown in table 1. In 
experiments 1, 2 and 4, infectivity was assayed by exposing 
half the mice in each experimental group to mosquitoes on 
day 12 p.i., and the other half on day 14 p.i. Preliminary 
experiments and other data (Taylor et al. 1997) showed that 
infectivity peaks during this period. 
Statistical analysis 
Comparisons of control and CQ-treated infections were 
made using univariate analyses of the following summary 
measures for each infection: 
(1) Total asexuals. This was estimated from parasite 
densities between days 8 and 16 p.i. Parasite densities prior to 
day 8 were not used because it was unclear whether parasites 
in the CQ-treated groups were dead or alive at the time of the 
smear, and by day 18 p.i. parasite densities were at very low 
levels. Estimates of total parasites between these days were 
obtained by integrating under the parasite density through 
time curves for each infection. This is a reasonably accurate  
measure of total numbers of asexuals (between days 8 and 16 
p.i.) because the asexual cycle of P. chabaudi is known to be 
24 h (reviewed in Cox 1988). 
Total gametocyles. Gametocytes of P. cliabaudi take 
approximately 2 d to mature (A. G. J. Buckling et at., 
unpublished data; Gautret ci al. 1997). An index of the total 
number of gametocytes produced by asexuals between eight 
and 16 days p.i. was therefore obtained by integrating under 
the gametocyte density through time curves between days 10 
and 18 p.i. This measure is not a direct estimate of total 
gametocyte numbers because gametocyte longevity is un-
certain, though the data presented below suggest few survive 
longer than 24 h. However, the sum of the gametocyte 
densities on each day is likely to be well correlated with total 
transmission probability: gametocyte densities at any point 
in time correlate with both the proportion of mosquitoes 
infected and oocyst densities within mosquitoes (Taylor & 
Read 1997). 
Index of gametocytogenesis (IG). This was calculated 
as the ratio of total gametocytes (2) to total parasites 
[(1) + (2)] for each mouse. 
Day of peak gamelocyte density. 
The proportion of mosquitoes infected. 
Prior to analysis, estimates of total asexuals and total 
gametocytes were log 10-transformed and indices of gameto-
cytogenesis (IG) square-root arcsin-transformed. All analyses 
were carried out using generalized linear models (GLIM; 
Crawley 1993). Starting with the highest order interactions, 
all factors (experiment, treatment (CQ +, CQ -) and, where 
relevant, day of CQ treatment or day of mosquito feed) and 
their interactions were individually removed in turn from the 
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maximal model. Non-significant factors were removed and 	
108 
test statistics obtained from the resulting minimal model. A 
binomial error structure, applying Williams's correction for 
overdispersion, was used for the logistic regression of infection 
probability (Crawley 1993). 
3. RESULTS 
Total asexuals and total gametocytes did not differ 
between experiments (F352 = 0.67, p = 0.58; F352 = 
0.44, p = 0.73, respectively). CQ treatment, however, 
had a significant effect, reducing asexuals to 20% of 
controls and gametocytes to 50% (figure 1, F152 = 
114.40, p < 0.0001; figure 2, F152 = 7. 10, p = 0.0 1, 
respectively). The effect of CQ did not differ between 
experiments (treatment by experiment interactions: 
F349 = 1.26, p = 0.3; F349 = 1.87, p = 0.15, asexuals 
and gametocytes, respectively). 
The index of gametocytogenesis (IG) was about 2.5 
times greater in CQ-treated infections than in control 
infections (F152 = 16.00, p <0.0001). There were no 
differences between experiments, nor did treatment 
effects differ between experiments (F352 = 0.76, p = 
0.52; F349  = 1.54, p = 0.22, respectively). Figure 3 
shows the relationship between total gametocytes and 
total asexuals for all infections. 
Peak gametocyte densities occurred approximately 
2 d earlier in CQ-treated infections than in control 
day of CQ treatment 
(a) 	
untreated 	--day5I  
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Figure 3. Total asexuals and total gametocytes (between 
days 8 and 16, and 10 and 18 p.i., respectively) for 
chloroquine-treated and untreated infections in experiments 
1-4. Mean (± s.e) index of gametocytogenesis (IG): CQ-
treated = 0.0180±0.0026; control = 0.0066±0.0012. 
infections for the experiments using CR (experiments 
1-3: F,, , = 54.86, p < 0.0001; figures 2 a—c) and 3 d 
earlier in the experiment using ER (experiment 4: 
F110 = 19.89, p = 0.001; figure 2d). For experiments 
1-3, the effect of treatment on timing of peak 
gametocyte densities did not differ between experi-
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Figure 2. Mean gametocyte densities (+ 1 se.) during infections for experiments 1-4 (a—d respectively). 
CQ, chloroquine. 
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• untreated 
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Figure 4. Mean proportions of mosquitoes infected (± 1 s.e.) 
for chloroquine-treated and untreated mice on days 12 and 
14 post-infection. 
0. 15, p = 0.86), but the timing of peak gametocyte 
densities differed between experiments (F239 = 4.46, 
p = 0.02). This was probably due to differences in 
timing of CQ treatment between experiments; there 
was no significant difference between experiments 
when CQ-treated groups were separated on the basis of 
specific day of treatment (p> 0.25 for controls and 
days 5 and 6 p.i. CQ treatment). Interestingly, there 
was a significant positive relationship between the day 
of CQ treatment and the day of peak gametocyte 
density for days 4, 5 and 6 p.i. CQ-treated groups 
in experiments 1-3 (ordered heterogeneity test (Rice & 
Gaines 1994): r 5P = 0.96, p < 0.01). 
There was no difference in total gametocytes 
between days 4, 5 and 6 p.i. CQ-treated groups in 
experiment 3 (F213 = 0.20, p = 0.83). IG, however, 
significantly differed between the groups (F213 = 4.38, 
p = 0. 035); pairwisc comparisons revealed the IG to 
be greater in day 6 p.i. CQ-treated infections than in 
those treated on day 4 p.i., but there were no other 
significant differences (Scheffe analysis p = 0.04, p> 
0.2 for both other comparisons). 
Proportions of mosquitoes infected were greater in 
CQ-treated mice than control mice on day 12 p.i. and 
vice versa on day 14 p.i. (figure 4; day by treatment 
interaction: x = 15.74, p < 0.001). There were no 
significant differences in overall proportion of mos-
quitoes infected between experiments, day and treat-
ment, and neither treatment nor day effects, and their 
interaction, differed between experiments (p > 0.2 in 
all cases). 
4. DISCUSSION 
Infections treated with CQ produced significantly 
fewer asexuals and gametocytes than untreated infec-
tions, but for a given number of asexuals, the number 
of gametocytes was about 2.5 times greater in CQ-
treated infections. This is most likely the result of 
increased gametocytogenesis following subcurative CQ 
treatment, consistent with our hypothesis. 
Changes in the relative mortality rates of gameto- 
cytes and asexuals cannot adequately explain the 
results. First, stage-specific mortality caused by CQ 
cannot be involved. The half-life of whole blood CQ-
concentration in mice heavily infected with P. chabaudi 
(21-25 % parasitized RBCs) is in the order of 7 h 
(Cambie el al. 1994). Parasite numbers were first 
assayed at least 2 d after treatment, when the CQ 
level must have been less than 0.5 mg kg; preliminary 
experiments revealed twice this concentration to have 
no noticeable effect on parasite numbers or infection 
dynamics. Moreover, virtually all the gametocytes 
counted must have been produced from post-treatment 
asexuals: any long-lived gametocytes present during 
the period of CQ activity would have made up only a 
tiny fraction of the gametocytes used to estimate sub-
sequent ganletocytogenesis because they were at such 
low densities when infections were drug-treated (figure 
2). Second, differential mortality resulting from dif-
ferences in immune response between the groups not 
only requires a gametocyte-specific clearance mech-
anism, for which there is currently no evidence (Taylor 
& Read 1997), but also one that is suppressed by CQ. 
The best explanation for the relative increase in 
numbers of gametocytes following CQ treatment is 
therefore increased gametocytogenesis, as predicted by 
both the safe-harbour and the fecundity compensation 
hypotheses. Nevertheless, the delay between CQ 
treatment (hence peak asexual density) and gameto-
cyte production (figures 1 and 2) is not entirely 
consistent with these adaptive hypotheses. Increased 
game tocytogenesis in response to stress might be 
expected to be immediate, resulting in mature gameto-
cytes 2-3 days later. Instead, we observed a delay of 
about a week. However, it is striking that in control 
infections there is also a delay of approximately a week 
between peak asexual density and peak gametocyte 
density. An intriguing possibility, consistent with the 
hypotheses, is that a sudden drop in parasite numbers 
might be acting as the cue for delayed gameto-
cytogenesis in both CQ-treated and control mice. In 
untreated infections, such a strategy would have the 
consequence of minimizing production of gametocytes 
during crisis, an immune-mediated response that 
down-regulates parasite numbers (Jarra & Brown 
1989) and during which gametocyte infectivity is 
greatly suppressed (Wery 1968). It is feasible that CQ 
treatment results in an artificially early occurrence of 
the same cue that stimulates this crisis-avoiding delay. 
Gametocytogenesis frequently follows a substantial 
reduction in overall parasite numbers (Sinden 1983; 
Carter & Graves 1988; Alano & Carter 1990; Sinden 
et al. 1996; figures 1 and 2), suggesting a positive 
relationship between gametocytogenesis and factors 
that correlate with parasite destruction. Such factors 
might explain how gametocytogenesis was triggered in 
control and CQ-treated infections despite radically 
different parasite dynamics (figures 1 and 2) and host 
condition in the two groups. Increased relative 
gametocytogenesis following CQ treatment might be 
explained by the resulting short-term very high rate of 
parasite destruction. This relationship would also 
explain why gametocytogenesis was greater in mice 
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The later treatment inevitably resulted in greater 
parasite death, both because by that stage there were 
more for CQ to kill (figure 1 c), and because of 
enhanced immune activity as a result of greater 
exposure, in terms of both time and numbers, to 
parasite antigens. 
Whatever the mechanism involved, these results 
clearly demonstrate increased game tocytogenesis fol-
lowing subcurative CQ treatment. As far as we are 
aware, this is the first fully controlled demonstration 
that subcurative treatment with an antimalarial drug 
can increase gametocytogenesis in Plasmodium, and thus 
alter patterns of infectiousness. The dose of CQ used in 
this study is equivalent to half the commonly recom-
mended dose for treatment of people with P.falciparum 
(25 mg kg- ' over 3 d; Desjardins et al. 1988). Because 
treatment often terminates following clinical improve-
ment, and drug-resistant parasites are common, 
subcurative treatment frequently occurs (Wernsdorfer 
1994). The results are therefore potentially relevant to 
the treatment of Plasmodium with CQ in the field. 
First, even large reductions in the numbers of asexual 
parasites may have a much less dramatic effect on 
infectivity because of compensatory investment into 
gametocytes. It is notable that in our transmission 
experiments, the proportion of mosquitoes infected was 
similar from treated and untreated infections (figure 
4). Second, transmission between hosts might actually 
be faster where subcurative treatment is common, 
because of the earlier timing of peak infectivity (figure 
4). Transmission may be further enhanced by the 
general reduction in host immunity because of de-
creased exposure to the parasite (Graves et al. 1988) 
and by the increased infectiousness of gametocytes 
apparently induced by very low level CQ treatment 
(Ramkaran & Peters 1969; Wilkinson et al. 1976; 
Ichimori et al. 1990). Finally, if the effect is a 
generalized stress response, it might be observed 
following treatment with most blood-stage anti-
malarials and even potential vaccines. 
Here we have only considered phenotypic modifi-
cations of gametocytogenesis. Consistent differences in 
gametocyte production between isolates of P.falciparum 
in vitro (Burkot et al. 1984; Graves et at. 1984) imply 
natural genetic variation in gametocytogenesis on 
which drug-imposed selection could act to generate 
long-term changes in resource allocation between 
asexuals and gametocytes. Parasites will probably 
increase their fitness under drug pressure by producing 
gametocytes in greater quantities earlier in the infec-
tions. Lines et at. (1991) suggested that just such 
adaptation may underlie increases in malaria trans-
mission in Tanzania following long-term CQ use. This 
is supported by a recent study in Sri Lanka that 
showed that infections of CQ-resistant parasites are 
more likely to be gametocyte-positive than infections 
of sensitive parasites (Handunnetti et at. 1996); under 
drug pressure, adaptive life history changes are likely 
to evolve in parallel with the development of drug 
resistance. Both short- and long-term parasite life 
history changes in response to intervention strategies 
are to be similarly expected in many disease-causing 
organisms. 
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